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CHARACTERISATION AND SPECIATION OF FUNGAL 
ISOLATES IN NEONATAL SEPSIS IN A TERTIARY 
CARE HOSPITAL. 
      
Abstract    Introduction:  Sepsis is the most common cause of neonatal mortality. 
Sepsis caused by fungal infections are a serious problem. This study is aimed to 
estimate the incidence of fungal sepsis, evaluate the risk factors and isolate the 
common fungal pathogen in neonatal intensive care unit(NICU) in a tertiary care 
hospital.          
 Materials and methods:  200 neonates were selected from NICU and 
blood, CSF or urine sample were collected for fungal culture. Fungal pathogens 
were isolated by conventional culture method, identification by microscopic and 
macroscopic observation of growth. Speciation of Candida  was done by germ tube 
test, corn meal agar morphology, CHROMEagar color, urea hydrolysis, sugar 
fermentation and sugar assimilation tests. Antifungal susceptibility testing was 
done by broth dilution, agar dilution and disc diffusion methods.   
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 Results:  From 200 samples, 13 fungal growth were isolated. The incidence 
of fungal sepsis was 6.5%. All the isolates were Candida species and non albicans 
Candida were predominent (77%). C.albicans (23%) and C.gullermondii (23%) 
were the most common species. There was male preponderance (54%) and outborn 
babies (62%) had more sepsis. The major risk factors were preterm (77%)  and 
very low birth weight (VLBW) (69%) and the associated risk factors were 
prolonged hospital stay more than 7 days (54%), administration of broad spectrum 
antibiotics for more than 5 days (61%)  and mechanical ventilation (46%). The 
isolated candida species showed more resistance to fluconazole (30%) and 
amphotericin B (23%).         
 Conclusions: The incidence of fungal sepsis in NICU was increased. 
Candida species were the common cause for fungal infection in neonates. Preterm 
and very low birth weight, prolong hospital stay, administration of broad spectrum 
antibiotics and mechanical ventilation were the major risk factors.  Nosocomial 
infection was considered as a major contributor. Routine  screening and evaluation 
can be recommended for prevention and control of fungal sepsis in NICU.    
 Key words: NICU, fungal sepsis, VLBW neonates, Candida species. 
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INTRODUCTION 
 
  Microorganisms infect humans by various routes like skin contact, 
respiratory system, gastrointestinal system, genitourinary system, direct spread 
through blood or transplacental transmission. In invasive infections the 
microorganism circulates through vascular system and affect any organ system of 
human body. Sepsis is a clinical syndrome which results in circulating 
microorganism which multiplies at a rate that exceeds their removal by 
phagocytes. The symptoms are produced by microbial toxins and cytokines from 
inflammatory cells.70         
 
Definition of sepsis:          
 'Sepsis' is defined as systemic  illness caused by microbial invasion of 
normally sterile parts of the body and systemic inflammatory (SIRS) response 
syndrome due to the invasion. This term differentiate an illness with identical 
clinical syndrome that can arise in several non-microbial conditions. SIRS defined 
as presence of at least two of the following signs like temperature above 38 ℃ or 
below36℃, tachycardia, increased respiratory rate or PCO2 below32 Torr, 
leukocytes above 12000/µl or below4000/µl or above 10 % of band cells. This 
becomes 'severe sepsis' when there is evidence of hypoperfusion or dysfunction of 
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at least one organ system. When there is persistence of hypotension in spite of fluid 
resuscitation or need for vasopressors ,it is termed as 'septic shock'.47,74 
 
Neonatal infection:           
Neonatal infections are unique in several ways. Infectious agents can be 
transmitted from mother to fetus or community acquired or may be nosocomial. 
Newborn infants are less capable of responding to infections and coexisting 
condition often complicate the diagnosis and management. The clinical 
manifestation is varying from subclinical to severe. There may be focal or systemic 
infection and rarely, congenital syndromes resulting from in utero infection. The 
etiologic agents are wide variety, including bacteria, viruses, fungi, protozoa and 
mycoplasma. Preterm, very low birth weight (VLBW) babies need a prolonged 
hospital stay which puts them at continuous risk for acquired infections.13 
 
Predisposing factors:          
  A newborn is deficient in various components of humoral and cellular 
immunity. The chemotaxis, phagocytosis, bactericidal activity and cytokine 
production are reduced due to immature polymorphonuclear and macrophages 
activity. Immunoglobulin and complement system are also immature, more so in 
premature neonates.140           
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Hospital Acquired Infection (HAI)        
 The term HAI (syn; Nosocomial) is applied to any infection causing illness 
that was not present or in its incubation period when patient entered hospital or 
received treatment in an outpatient or accident and emergency department.78   
 
HAI in neonates:           
 The Centers for Disease Control and Prevention (CDC) defines HAI in 
neonates as any infection that occur after admission to NICU and that was not 
transplacentally acquired. It is also defined as any infection occurring more than 5 
to 7 days after birth in a hospital delivered babies.   
 
Impact of  HAI in newborn care:         
 Rates of HAI in well maintained newborn nurseries are low, ranging from 
0.3 to 1.7 per 100 newborns.  Rates of healthcare-associated neonatal infections are 
3 to 20 times higher in resource limited countries.  Low birth weight is a major risk 
factor for HAI with each 100g decrease in birth weight conferring an additional 9% 
risk of BSI. Infection rate is increased in NICU due to overcrowding, invasive 
procedures, more exposure to infectious agents and contamination of 
environment.16 
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Importance of newborn care:        
 Newborn health is the key marker of child health. Above 50% of under five 
child deaths occur during newborn period. In that,  most of newborn deaths (40%)  
occur within 24hrs.139   
  Newborn death is decreased due to improved maternal care, well 
established delivery system and advancement in neonatal care. But newborn deaths 
are still accounted for higher share of global child death. Most of the deaths happen 
in just five large countries-India, Nigeria, Pakistan, China and Democratic 
Republic of Congo. Three major causes of neonatal death in the world are preterm 
delivery (29%), asphyxia (23%), and severe infection (25%).59 
 
Infant mortality rate (IMR): 
  Infant mortality rate (IMR) is defined as the ratio of infant deaths that are 
registered in a given year to the total number of live births registered in the same 
year, usually expressed as a rate per 1000 live birth. Neonatal death is the death 
that  occur during the neonatal period  starting from birth to 28  days of life.96  
 
Neonatal mortality ratio (NMR):        
 Neonatal mortality ratio (NMR) is the number of neonatal death in a given 
year per 1000 live birth in that year.96      
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Incidence in India:          
 India accounts for 20% of global births and 30% of global newborn deaths. 
Infections (33%), asphyxia (21%) and prematurity (15%) are the leading causes of 
neonatal deaths in India. Most of this death can be prevented in various levels such 
as awareness in community level, maternal health care and  new born care.99 
 In India under five mortality in 2012 was 56, IMR was 44 and NMR was 31 
per 1000 live birth.  IMR in Tamil Nadu  was 21 per 1000 live birth.40  
 
Neonatal sepsis:           
 The clinical spectrum of neonatal sepsis begins with a localized infections  
( like meningitis, pneumonia and pyelonephrits) or from systemic infections ( by 
bacteremia, fungemia and viremia). Then there is systemic inflammatory response 
syndrome (SIRS), which may   progress  to severe sepsis (sepsis combined with 
organ dysfunction), septic shock (persistence of hypoperfusion or hypotension), 
multiple organ dysfunction syndrome (MODS) and even death. Initial presentation 
may be limited to only one system, but involvement of another system should also 
be evaluated.91     
 
Classification of neonatal sepsis:        
  Neonatal sepsis can be classified into two major categories according 
to the time of onset          
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 Early onset of sepsis (EOS) presents within the first 72 hours of life. In 
severe cases, the neonate may be symptomatic at birth. Infants with EOS usually 
present with respiratory distress and pneumonia. The source of infection is 
generally, the maternal genital tract. Some maternal / perinatal conditions have 
been associated with an increased risk of EOS. Knowledge about this potential risk 
factor would help in early diagnosis of sepsis. The following factors such as low 
birth weight and prematurity, intrapartum sepsis, rupture of membranes for more 
than 24 hrs, prolonged labor, perinatal asphyxia and foul smelling and meconium 
stained liquor seem to be associated with an increased risk for early onset sepsis.39 
 Late Onset Sepsis (LOS) presents after 72 hours of age. The source of 
infection in LOS is either nosocomial or community acquired and neonates usually 
present with septicemia, pneumonia or meningitis. Various factors that predispose 
to it which includes low birth weight, prematurity, admission in intensive care unit, 
mechanical ventilation, invasive procedures, administration of parentral fluids, and 
usage of stock solutions. Factors that might increase the risk of community 
acquired LOS include poor hygiene, poor cord care, bottle feeding, and prelactal 
feeds. In contrast, breastfeeding helps in prevention of infections.39    
 Aspiration of infected amniotic fluid may produce pneumonia and sepsis in 
utero, manifested by fetal distress or neonatal asphyxia. Exposure to pathogens 
during delivery and in the nursery care or community is the mechanism of 
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infection after birth. The physiological manifestations of the inflammatory 
response are mediated by a variety of proinflammatory cytokines, principally 
Tumor necrosis factor (TNF), Inter leukin - 1 (IL-1) and IL-6 and byproducts of 
activation of the complement and coagulation systems. Elevated levels of IL-6, 
TNF and Platelet activating factor have been reported in new born infants with 
neonatal sepsis. IL-6 is the cyokine most often elevated in neonatal sepsis.88  
 
Etiological agents:          
 The common etiological agents for EOS are Group B Streptococcus(GBS), 
Escherichia coli(E.coli), Streptococcus viridians, Enterococcus species, 
Staphylococcus aureus (S.aureus), group D Streptococcus, Pseudomonas and other 
Gram negative enteric bacilli. In LOS the common organisms are coagulase 
Negative Staphylococcus (CoNS), S.aureus, E.coli, Klebsiella spp, Candida spp, 
Enterococcus spp, Pseudomonas and group B Streptococcus(GBS).89  
 Outbreaks of viral infection in NICU can be serious and difficult to control.  
Enteroviruses such as echovirus 11, adenovirus 7 & 8, rotaviruses and respiratory 
syncytial virus( RSV) may be responsible for most cases.79    
 
Clinical presentation of sepsis:       
 The earliest signs of sepsis are often subtle and nonspecific; indeed a high 
index of suspicion is needed for early diagnosis. Neonates with sepsis may present 
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with one or more of the following symptoms and signs such as hyper/hypothermia,  
fever, lethargy, poor cry, refusal to suck, poor perfusion, Hypotonic, absent 
neonatal reflexes, bradycardia or tachycardia, respiratory distress, apnoea and 
gasping respiration, hypoglycemia or hyperglycemia and Metabolic acidosis. 64 
  
Fungal infection: 
 Fungal infections are common and some of them are serious and even fatal. 
Most bacterial infections have been managed well, but fungal infection has not 
been so. Most fungi are saprophytes in the soil and human mycosis infections also 
cause  as many fatalities as whooping cough, diphtheria, scarlet fever, typhoid, 
dysentery and malaria.4           
 Apart from bacterial pathogens, fungi also causing systemic infections and 
sepsis in NICU. This fungal sepsis is mostly nosocomial and known hazard of 
prolong life support techniques like ventilator care, venous catheterization, 
exchange blood transfusions and total parentral nutrition(TPN), prolonged 
antibiotic administration for bacterial sepsis.83      
  
Fungal pathogens in neonatal infection:   
 Fungi are ubiquitous environmental organisms, also frequently found in 
hospital environment.  Fungal infections are common in neonates and presented as 
a trivial mucocutaneous infection to life threatening fungemia and deeply invasive 
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mycosis. Among the fungal pathogens, Candida species is the dominant one, and 
there is equal distribution between C.albicans and non albicans candida(NAC) 
species. Other fungi isolated in neonatal infections are Aspergillus fumigatus, 
A.flavus, Malassezia furfur, M. pachydermatis. From invasive fungal dermatitis, 
apart from Candida species and Aspergillus species, Tricosporon beigeli and 
Curvularia  species are rarely isolated. Candida species are the third most common 
cause of LOS in the NICU, but the mortality is sevenfold higher than 
Staphylococcus epidermidis.85           
 
Pathogenesis of fungal infection:       
 The pathogenesis of fungal infections involves adherence, colonization, 
infection and dissemination. Surface glycoprotein help in fungal adherence. In 
yeast cells, surface glycoprotein-INT1 binds to beta- integrins present on the 
endothelium and WBCs. Filamentous form of fungus have increased virulence in 
immunocompromised patients.26         
 Aspergillosis generally follows inhalation of spores but also enter directly 
into wounds or during surgery.  It is  presented as allergic form, non invasive 
colonization and invasive Aspergillosis. Invasive Aspergillosis is mainly chronic 
necrotizing pulmonary and also disseminated to any organ system of human 
body.15            
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Malassezia yeasts interfere with melanin production in skin. It requires free fatty 
acids for survival. TPN with lipid hyperalimentation leads to entry trough 
intravenous line. The usual manifestation is lipid deposits in pulmonary arteries.8
 Zygomycosis infection can occur by inhalation, percutaneous inoculation or 
ingestion. They have a predilection for elastic lamina of large and small arteries 
causing thrombosis, hemorrhage and infarction.57        
 
Immunity against fungal infection:       
 Fungi are eukaryotic organisms and its protein synthesis machinery and 
mechanisms to organize and replication of the genome are similar to mammalian 
cells. Phagocytes particularly neutrophils and macrophages are essential for killing 
fungi either by degranulation and release of toxic materials in to hyphea or 
ingestion of yeast or conidia. Most fungi are highly immunogenic and induce 
strong antibody response and T cell mediated immune response. Considerable 
evidence proves that dominant protective role of TH 1 and phagocyte activation is 
important than antibody mediated response. Fungi possess many evasion strategies 
to promote their survival. In Candida species, concealing the beta Glucans of their 
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Risk factors for fungal infection: 
  Risk Factors for Invasive Fungal infection(IFI)  in neonates are gestational 
age < 32 weeks, birth weight ≤ 1500g, male gender, APGAR score below 5 at 5 
minutes, intubation and mechanical ventilation, placement of indwelling devices, 
umbilical catheters, peripheral or central venous catheters, urinary catheters, 
cerebrospinal fluid shunt devices, abdominal surgery, lack of eternal feeding, use 
of intralipid,  total parenteral nutrition(TPN) supplementation, corticosteroid use, 
use of histamine type 2 receptor blockers and prolonged antibiotic administration.33    
 
Candida infection:         
 Neonates are a special population at risk of Candidemia and disseminated 
candidiasis. For some 2000 years after Hippocrates described thrush in the mouths 
of babies, the infection was viewed as an annoying and insignificant superficial 
disease. Only within the past century, Candidiasis of deep organs has been 
recognized. Since the 1960s, certain important therapeutic and diagnostic advances 
in medicine have affected host defenses and microbial ecology to the extent that 
these ubiquitous yeasts have gained prominence as pathogens of the first order 
with capabilities of producing life-threatening disease.63     
   Candida exists in three different morphological forms. Yeast 
cells or blastospores have oval to round in shape, double walled chlamydospores 
usually located at the end of a pseudohypha and pseuodomycelium- a mass of 
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pseudohypha mostly in tissues. 104       
 It manifests as congenital cutaneous candidiasis, mucocutaneous  
candidiasis, urinary tract infection, blood stream infection and disseminated 
infection. C.albicans is the most frequently isolated yeast species in the  specimen 
taken from infected neonates.  Neonates and pregnant women have impaired host 
resistance to Candida species. Advances in health care have decreased the 
mortality for many conditions also have been associated  with changes in host 
defense and normal flora, which have in turn led to a large population at risk for 
invasive Candida infection.66     
 
Non albican Candida:           
 Although Candida albicans remains the most common fungal pathogen 
isolated from blood and body tissue, recent literature have shown an increased 
prevalence of non albican Candida (NAC). NAC (c.parapsilosis, c.tropicalis, 
c.glabrata) exhibits varying levels of resistance to flucanazole and other antifungal 
agents .Small percentage of infection are due to C.lusitaniae, C.gulliermondii, 
C.dubliniensis.58       
 
Disseminated Candidiasis:         
 Disseminated candidiasis may present with several entities like meningitis, 
endocarditis, renal abscess, endoptholmitis, CNS absecess, ventriculitis and liver 
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absecess. It is recognized, when infant fails to respond antibiotics or when  these 
infants have unexplained feeding intolerance, Cardio vascular instability, apnea, a 
new (or) worsening of respiratory failure,  increasing ventilation requirement, 
lethargy, convulsions and poor activity. There may be thrombocytopenia,  
hyperbilurubinemia, elevated C-reactive protein (CRP) and glucose instability 
(hypoglycemia or hyperglycemia).114     
 
Malassezia infection:        
 Malassezia species is dimorphic lipophilic yeast. Malassezia furfur is   
isolated from neonates and has been associated with fungemia and occasionally 
pneumonia in premature infants with low birth weight who are receiving liquid 
emulsion alimentation through central venous catheters. Sporadic bloodstream 
infections have been described, with transmission probably by the hands of 
medical personnel. Malassezia pachydermatis has also reported in VLBW infants 
with sepsis.129          
 
Aspergillus infection:        
 Invasive infections with filamentous fungi are rare, but sporadic cases 
reported. Aspergillosis is less common than invasive Candidiasis in newborn and is 
usually a primary cutaneous disease. Aspergillus fumigatus is the most common 
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species followed by A. flavus in invasive Aspergillosis. Prematurity is one of the 
main risk factor. The lung is the most commonly affected organ.129 
 
Zygomycosis:         
 Zygomycosis, a filamentous fungi infection usually start at a site of  local 
trauma or intravenous catheter insertion site or infiltrate and progress to a 
necrotizing soft tissue infection. Most of it presented as gastrointestinal infection 
and some mimics Necrotizing EnteroColitis (NEC). Early diagnosis and treatment 
needed to prevent rapid fatal dissemination.  The common species are Rhizopus, 
Mucor and Rhizomucor.35       
 
Tricosporon infection:        
 Tricosporon  beigelii rarely isolated from invasive fungal dermatitis. It leads 
to systemic complication like endocarditis, brain abscess, pulmonary infections and  
endophthalmitis.35         
 
Admission criteria for newborn:       
 The admission criteria for neonatal intensive care unit (NICU )  are  birth 
weight <1800g or gestation <34 week, large baby >4.0kg ,refusal of feeds, 
respiratory distress( rate >60/minute, grunt, retractions), severe jaundice, 
hypothermia <35.4℃ , hyperthermia >37.5℃, central cyanosis, shock ( cold 
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periphery, CRT >3sec ),  coma, convulsions, encephalopathy, abdominal 
distension, diarrhea, dysentery and  major malformation, These newborn babies 
have features of sepsis or more prone for sepsis.97    
 
Diagnosis of fungal infection:        
 A high index of suspicion and early diagnosis is needed to reduce the 
morbidity and mortality. Isolation of the causative agents from a relevant clinical 
specimen, screening for hematologic markers, serological tests and molecular 
studies are useful for diagnosis of fungal infections.      
  
Septic screen:            
 All neonates suspected to have sepsis should have a septic screen to 
correlate the diagnosis. The various components of the septic screen include total 
leukocyte count, absolute neutrophil count, ratio of immature neutrophil to  total 
neutrophil count(I/T ratio), micro-erythrocyte sedimentation rate(micro-ESR) and 
C reactive protein(CRP). The absolute neutrophil count varies considerably in the 
immediate neonatal period.109        
 
Definitive diagnosis: 
 Isolation of organism by fungal culture from various samples like blood, 
CSF and urine is the standard test. Speciation done by observation of culture 
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growth morphology, microscopic structures and  specific confirmatory biochemical 
tests. Antifungal susceptibility is mandatory now a days to guide the clinician for 
the treatment and to prevent the drug resistance.86   
 
Serological tests:         
 Fungal serology tests are tube precipitation, immunodiffusion, latex 
agglutination and complement fixation. Enzyme immunoassay with species 
specific monoclonal antibody, nucleic acid probe assay and polymerase chain 
reaction (PCR) also used in some laboratories. Fungal antigens that used in rapid 
diagnostic tests are Galactomannan in invasive Aspergillosis and  Beta-D glucan, 
mannan in candida infection.69    
 
Monitoring: 
 In a suspected or proved cases of Candidiasis, additional tests like complete 
blood count (CBC), blood urea nitrogen, creatinine, potassium and liver enzymes 
should be done. End organ dissemination should be screened by 
Echocardiography, Renal ultrasonography, neurosonogram and indirect 
ophthalmoscopy  for every newborn.76    
 
Management:         
 Prompt initiation of systemic antifungal therapy, removal or reduce the 
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exposure of indwelling catheters, minimize the contamination and supportive care 
are needed to prevent dissemination and improve outcome.       
 
Supportive care: 
 Adequate and proper supportive care is crucial in a sick neonate with sepsis. 
This cases should be nursed in a thermo-neutral environment taking care to avoid 
hypo or hyperthermia. Oxygen saturation should be maintained in the normal 
range, mechanical ventilation may have to be initiated if necessary. If the infant is 
hemodynamically unstable, intravenous fluids should be administered.143   
 
Antifungal therapy:          
 There are some guidelines outlining the choices for optimal therapy in the 
treatment of neonatal fungal infection.  Amphotericin B deoxycholate, a polyene 
antifungal drug with broad  spectrum of activity is the mainstay of therapy.  
Amphotericin B deoxycholate is better tolerated in neonates.  Lipid formulation of 
Amphotericin B reduces the nephrotoxicity and infusion related toxicity.  
C.lusitaniae is resistant to Ampotericin.  Flucytosine (5-FU), a fluorine analog of 
cytosine , mostly used in combination with Amphotericin B.42    
  Flucanazole is a fungistatic  that inhibit the production of  ergosterol in 
fungal cell membrane. It is the only agent used in neonatal populations with 
significant research data. Fluconazole is inactive against all strains of C.krusei and 
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some of C.glabrata and also not useful against Aspergillosis, Zygomycosis. 
Another azole  Voriconazole is active against C.kruesi, C,glabrata and 
Aspergillosis but not effective for zygomycetes.42      
 Echinocandins, a newer class which target the cell wall by inhibition of (1, 
3)-Beta-D-glucan  synthase  complex. Caspofungin is approved to treat 
Aspergillosis and Candida infection in neonates. Studies are underway to 
determine the effectiveness of this drug in neonatal patients.42   
 
Prophylaxis:         
 Fluconazole is used for prophylaxis in many NICUs to reduce the fungal 
colonization and prevent the invasive infection among VLBW babies.  It is advised 
as dose of 3mg/kg twice weekly and continued up to 6 weeks. Newborns in NICU 
who receive prolonged antibiotic therapy and on CVC are also benefited by 
prophylactic Fluconozole.77          
Nystatin, a polyene antifungal used topically and orally to prevent colonization 
over skin, mucus membrane  and gastrointestinal tract. It is safe, inexpensive and 
well tolerated drug.38       
 
Prevention:           
 Principles for the prevention of nosocomial infection include adherence to 
universal precautions, avoiding nursery crowding, strict compliance with hand 
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washing, meticulous neonatal skin care, minimizing the risk of catheter 
contamination, decreasing the number of veni-punctures and mechanical 
ventilation days and providing education and feedback to nursery personnel. 
Surveillance for HAI is essential for prevention and control of sepsis. 
Infrastructure designing with adequate space and equipments, regular 
decontamination and cleaning of nursery, sufficient staffing in NICU and 
screening, periodic health check up, vaccination for employee are all helpful 
measures in prevention.71         
 Apart from diagnosis and treatment of bacterial sepsis in NICU, fungal 
infections and sepsis are also an important problem. There are gaps in 
understanding and there is an urgent need for studies about simple and sustainable 
intervention to reduce the burden of neonatal sepsis. To reduce the morbidity and 
mortality by fungal infection, a better understanding of the incidence, diagnosis, 
management, definite therapy and prophylaxis is essential. Assessment of risk 
factor, clinical features and investigation profile and isolation of fungal pathogen 
by this study will help in early intervention with antifungal treatment. It will also 
leads to a good clinical outcome in neonatal sepsis cases, decrease the morbidity 
and mortality among these cases, decrease the duration of hospital stay and 
treatment cost in NICU. 
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    Aims and Objective 
 
Aims and Objective are:- 
 
1. To study the Prevalence of neonatal fungal sepsis. 
 
2. To identify the risk factors for development of fungal sepsis in neonates. 
 
3. Characterization and speciation of the fungal isolates and test the antifungal 
drugs susceptibility pattern. 
 
4. To guide the clinician for the appropriate treatment with antifungal drugs and 
help to improve the clinical outcome. 
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Review of Literature 
Neonatal sepsis           
  Stoll BJ (1997), has documented in his article 'The Global Impact of 
Neonatal Infection', sepsis is the commonest cause of neonatal mortality and it is 
responsible for 30-50% of the total neonatal deaths in developing countries.131This 
was also reported by Agrawal et al, (2001).2      
 Vergnano et al,(2005) reported incidence of neonatal sepsis varied from 7.1 
to 38 per 1000 live births in Asia, 6.5 to 23 per 1000 live births in Africa, and 3.5 
to 8.9 per 1000 live births in South America.138      
  A study in Nigeria by U. Edewochi et al,(2012) stated that perinatal 
asphyxia, LBW , neonatal sepsis and neonatal jaundice were leading cause of 
admission in NICU. In out born babies delay in seeking care and diagnosis was 
significantly affecting the outcome.33        
 Neonatal sepsis is predominant among male infants. Term male infants have 
an approximately twofold higher incidence of sepsis than term female as stated by 
Washburn et al, (1969).142         
 Neeraj kumar et al, (2010) stated that 72% male neonates were affected by 
neonatal sepsis in their study.93 The gene located at X chromosome is involved 
with the function of thymus or with the synthesis of immunoglobulin. Double X 
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chromosome in female gender leads a greater resistance to infection. This was 
explained by Bellani AJ, Schlegel, (1969), in the textbook of Infectious Disease of 
the Fetus and Newborn.14         
 Cloherty J P and Strak R, (1998) classified neonatal sepsis into two major 
categories depending upon the onset of symptoms. Early onset sepsis presents 
within 72 hrs of age and late onset sepsis presents after 72 hrs of age. 23  
 Franciosi et al, (1973) observed generalized disease takes two clinically and 
epidemiologically distinct forms, early and late onset. By comparison, United 
States and Australia 1.5 to 3.5 per 1000 live births affected by EOS and 6 to 9 per 
1000 live births by LOS.36         
 Reports from India  showed  50-60% of  septic babies were premature babies 
and very low birth weight babies. This was documented by Bang et al, (2001).12 
Based on study from India by Singh et al,(1994) identified the risk factors 
associated with early onset sepsis.127  Sundarm et al,(2009) studied the incidence 
of neonatal sepsis, it was found that the incidence of LOS increased from 12 to 
16.5 per 1000 live births and the incidence of EOS remains at 3.5 to 8.9 per 1000 
live births.133           
 Kanya Mukuhopadhyay et al,(2012) reported that major causes of 
mortality in ELBW neonates are sepsis (46%). birth asphyxia (20%) and 
pulmonary hemorrhage (19%).62       
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 The increased incidence of septicemia among premature neonates was 
attributed to their poor immune response like low level of IgG, impaired cellular 
immunity and poor immune response and poor mucosal defense according to 
Schreiber et al (1992).120        
 Haque K H (1988) has defined 'Neonatal Septicemia' is a clinical syndrome 
characterized by systemic signs and symptoms in the first month of life. It 
encompasses systemic infections of newborn including meningitis, pneumonia, 
arthritis, osteomyelitis and urinary tract infection of the new born.46  
HAI             
 In a study by Sengupta, et al(2010 ), the incidence of catheter related BSI 
for CVCs or PVCs  were increased  in first three weeks, but if indwelling duration  
was above 35 days there were more risk (33%/day). Umbilical catheter for >4 days 
was found to increase the risk of sepsis dramatically.105     
 In their study Auriti C et al,(2003) suggested that approximately one third 
of nosocomial infections had been prevented by effective infection control 
protocols. Despite surveillance and preventive measures, the risk was  higher in 
NICU.9            
 Late-onset-sepsis is either nosocomial (hospital-acquired) or community 
acquired and neonates usually present with septicemia, pneumonia or meningitis 
according to Wolach B (1977).145        
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 In developing countries the incidence of  nosocomial infection was studied 
by Zaid et al,(2005)  and it varied between 18% and 34% and it accounted for as 
much as 40% deaths in neonatal units. 149      
  In a Brazil study about  incidence of nosocomial infection by Karla Dal-
Bo et al, (2012) reported about 33% mortality in NICU, which was equal to any 
other developing countries. There was 78% of bloodstream infection noted in that 
study. 65 
   In a national point prevalence study in US by Sohn AH et al, (2001)  
reported  nosocomial infection rate of 11.4%. The major interventions noted 
among those infections were CVP associated 23.3%, ventilator associated 22.9% 
and TPN associated 23%.128             
 In Taiwan, Bai-Horng, et al,(2007) studied about the distribution of 
pathogens for nosocomial infections in NICUs and there was 10.5% of fungal 
pathogens in bloodstream infections.10        
 Surveillance and Control Pathogens of Epidemiological Importance 
(SCOPE) investigators analyzed about HAI-BSI outcome of 49 medical centers in 
US and noted a crude mortality rate of 27% and 40% for candida spp. during 1995 
to 2004.144           
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Fungal sepsis:          
 Paolo Manzoni (2013) stated that, fungi were the third most common agent 
of late on set sepsis (LOS) in preterm neonates. Invasive fungal infection (IFI) was 
usually preceded by its colonization. Colonized CVC was associated with tenfold 
high risk for progression of sepsis.  Prophylactic Flucanazole greatly reduced the 
risk and oral Nystatin are also effective.94     
 Changing Pattern of neonatal fungal sepsis in a developing country Studied 
by Daynia E. Ballot et al (2013) in South Africa and reported the incidence of 
fungal BSI in neonates increased over time (0.6% in 2007 to 1.8% in 2011).27 
 Richard A, et al, (2003) tabled  the infectious pathogens in NICU. Among 
the fungal pathogens, Candida species were the third most common isolates in 
blood stream infections and sepsis and Malassezia species were also isolated less 
commonly in TPN supplemented newborns . Candida species also isolated from 
urinary tract infections, endocarditis, CNS infections and osteoarthritis. Aspergillus 
species isolated from skin, soft tissue or surgical site infections and it was 
categorized as less common one.107      
 The incidence of systemic fungal infection in newborn had been observed by 
Stoll BJ, et al (1996) , which ranged from 2.2% to 12.9% among VLBW  babies 
and from 3.5% to 16.3% among ELBW babies.130    
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 A prospective study was conducted by Rolides et al on invasive candidiasis 
in the NICU of Aristotle University in Hippokration hospital (1994-2000), 
observed that overall incidence of 1.28% and overall mortality for C.albicans is 
more (39.5%) than C.parapsilosis (11.1%).111     
 A prospective population based study for candidamia in Spain by Rodriguez 
D, et al,  (2002-2003),resulted with an annual incidence of candidamia 32.6 cases 
per 100,000 live births and 1.1 cases per 100 discharged cases from NICU.110  
 A surveillance study about fungal colonization by Tushar  BP et al (2007), 
showed significant decrease in fungal colonization by Fluconazole  prophylaxis for 
the first 28 days  period in extreme premature neonates with birth weight below 
1000 grams and gestational age at birth below 30 weeks. Non albicans candida  
become a frequent fungal species in colonization and infection in NICU especially 
in VLBW neonates.134         
 Clerihew et al, (2005) estimated the incidence of invasive fungal infection 
(IFI) was 10 cases 1000 per live born VLBW infants in a national prospective 
surveillance study at UK. They isolated fungal pathogen from 92 VLBW infants, 
and most of them were candida species (87/92). There were two Malassezia 
species, one Aspergillus species, one Rhizopus species and one  unidentified yeast 
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also isolated. The mortality among  above was  40% due to invasive fungal 
infection.20            
 In North India Singh K et al,(1999) reported incidence of 22.8%  of invasive 
fungal infection in preterm babies who stayed  for more than one week in NICU.126 
 VP Baradkar et al (2008), reported a case of neonatal septicemia due to 
Candida dubliniensis in a premature infant. C.dubliniensis is a part of normal flora 
of gut. But it is an emerging pathogen that can cause invasive disease. 141 
 Rabindra N. Misra et al (2013) isolated one Candida species, 
C.parasilopsis among 75 blood culture positive neonatal sepsis cases in a screening 
study at a NICU, tertiary care center in Pune. CRP was positive for 68 cases of 
positive blood culture newborns.103        
  Procinary RS, et al (2007), documented that fungal sepsis was more 
common in the severe premature infants, newborns under mechanical ventilation 
support, long term parenteral nutrition, with hypoglycemia and exposed to multiple 
antibiotic therapy.  Candida species were the major pathogens for fungal sepsis 
and transmitted from maternal flora or from nosocomial infection. The mortality 
rate was 45.8% and the majority of affected neonates had been associated with risk 
factors like  assisted ventilation, mechanical ventilation, nasal continuous positive 
airway pressure(CPAP) ventilation. There was high prevalence of surgical 
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problems (44%) like necrotizing enterocolitis among the fungal sepsis cases. 
Abdominal Surgery was  also  a risk factor  for fungal sepsis in neonates.102 
 Daniel K. Benjamin et al (2010) reported that invasive candidiasis 
increased the risk of death. It was highest among the neonates whom candida 
isolation from multiple sources. (eg urine and blood (or) urine and CSF).Nearly 
60% of infants with invasive candidiasis died.25      
 Baley et al(1991) study was showed that Candida species rapidly colonize 
the skin and mucus membrane of about 40-60% in critically ill infants and can 
progress to invasive infection. Usage of  Fluconazole prophylaxis  in extreme 
premature newborns, BW <1000grams and gestational age below 27 weeks had 
been proved to a good option for prevention of fungal sepsis .Resistant to 
Fluconazole was also reported for some of the cases. So prophylactic use of 
flucanazole  needs caution.11         
             
 In Brazil, three cases of C. krusei were reported in a study of neonatal fungal 
sepsis by Selma et al (2012). It had been recognized as a potentially multidrug 
resistant fungal pathogen with intrinsic resistant to Flucanazole and decreased 
susceptibility to amphotericin B . Resistance pattern of C.parapsilosis was more for 
Fluconazole(5.4%)  but voriconazole resistant also noted in some isolates.122 
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Candida : 
 Candidiasis is a "white plague" of the immunocompromised host. Clinical 
expression of the disease implies debility, ranging in magnitude from the weak 
neonate to the individual with a profound congenital or acquired 
immunodeficiency disorder. Exposure  via horizontal and vertical transmission, 
from vaginal candidiasis in pregnant mothers and hand colonization of care givers. 
A study about annual incidence of neonatal candidemia conducted during 1995-
2004, and the attack rate of candida (Blood stream infections per 100 patients) and 
incidence density (BSIs per 1000 days) was determined. Among the ELBW 
neonates the incidence was decreased from 3.51 (1995 to 1999) to 2.68 (2000-
2004). There were 1997 cases of BSI's, most common organism was Candida 
albicans and also  C.tropicals, C.lusitaniae, C.glabrata and C.krusei were also 
isolated. This study justifies the fluconazole prophylaxis for candidial 
colonization.121 
 Vandhana Sardana, et al (2012) reported candidemia in 30% of cases of 
neonatal sepsis and the NAC species were predominant in their study. There was a 
changing trend in neonatal candidemia.136       
 Rippon JW (1998) described about iatrogenic and barrier break Candidiasis 
that was resulted from wide variety of insults to the neonates who were admitted in  
intensive care. Colonization and invasion was  occurred  in association with 
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indwelling catheters, hyperalimentation and surgical procedure or simply through 
intramuscular or intravenous  injections and during lumbar puncture procedure that 
spreads directly to central nervous system(CNS).108     
 Ray TL (1989) described an additional aspect of Candida, that there was a 
capacity to undergo high frequency “phenotype switching” within single strain, 
which probably contributes to the pathogenicity of some strains,. That phenotypic 
variability were represented in an individual cell or yeast colony, drug sensitivities 
and secretion of protective virulence factors like  acid proteinase. Rapid 
differential gene expression by the organism might allow important pathogenic 
adaptability of the organism to the host environment.109     
  Malassezia pachydermatis, an animal pathogen, can also colonize 
infants in the NICU and cause fungemia in association with intravenous 
administration of lipids. Invasive fungal dermatitis is an entity that is recognized 
increasingly with the infants with VLBW. These infants have the same risk factors 
for invasive fungal infection as described for neonatal candidiasis. Invasive 
infections with filamentous fungi are rare in the newborn, but sporadic cases of 
aspergillosis and zygomycosis have been reported. Aspergillus infections in 
neonates present as cutaneous or disseminated disease. Gastrointestinal infections 
account for more than 50% of reported cases of zygomycosis in neonates; some 
cases mimic NEC. Extreme prematurity, acidosis, renal failure, and treatement 
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with steroids are risk factors for invasive mold infections. Mortality rates are high, 
and diagnosis is often made only at autopsy.16     
 Zygomycosis was reported by Roildes E et al,  (2009)that >70% of the 
infection were in the premature newborns and most common forms were GIT 
(>50%) and cutaneous(35%). The mortality was 85% among the disseminated 
disease.          
 Maxson, et al (1992)  reported pulmonary blastomycosis in neonates who 
were developed acute onset of respiratory distress and described the cause was 
aspiration of vaginal secretion during birth.83      
 Aspergillosis in neonates was reported by Groll, et al (1998), that it was 
uncommon disease in the newborn period and usually manifested as widely 
disseminated disease. Primary cutaneous disease had been increasing in premature 
infants.14             
  Malassezia colonization in neonates studied by Shattuck, et al (1996) and it 
was varied from 30-100%. The factors correlated for it were length of 
hospitalization, duration of central or peripheral venous line, usage of total 
parentral nutrition(TPN),  use of occlusive dressings and lower gestational age. 
Invasive disease was more among TPN supplemented newborns.125 
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Risk factors :  
 According to Roy et al., (2002) the most frequent neonatal risk was low 
birth weight affecting 63.8% of the neonates. Study of maternal risk factors 
revealed 32.08% of mothers have preterm labor, 28.9% had PROM and 5.2% had 
intra partum fever. 113         
 Shah et al 2006 have reported premature rupture of membranes contributed 
to 46% of cases of neonatal sepsis in their study. It was associated with early onset 
sepsis and there was ascending infection from cervico-vaginal epithelial 
colonization. It was also associated fungal infection from vaginal Candidiasis.124 
 According to Shabina  Ariffet al,(2011)  prolonged mechanical ventilation 
care more than 7days, , prolonged duration of hospital study more than 7days 
positive bacterial blood culture report and escalating antibiotic usage without 
proper antibiotic sensitivity report were the major risk factors for Candidemia in 
NICU. Antenatal care had a protective impactMechanical ventilation is one of the 
life saving measures in severe birth asphyxia, preterm neonates with severe RDS, 
meconium aspiration syndrome with respiratory failure, severe sepsis with multi 
organ dysfunction, metabolic acidosis and some cases of neonates under post 
operative care. Such a important intervention may increase the chances of invasive 
infection and sepsis.123        
 According to Kristof K et al (2009), preterm (30weeks), Very Low Birth 
 46  
Weight (VLBW) babies below 1500gms, Extremely Low Birth Weight (ELBW) 
babies below 1000gms had increased risk for initial intensive care. These above 
factors increase the changes of fungal colonization over skin, GIT, and Respiratory 
mucosa, led to invasive fungal infections and sepsis. Therefore this fungal sepsis 
would continue to be a challenging complication in neonatal intensive care  and 
also affecting morbidity and mortality.72    
 
Signs & symptoms:         
 According to WHO Young infant study group, clinical criteria for 
diagnosis of sepsis were convulsions, respiratory rate >60 breaths /min , severe 
chest indrawing, temperature >37.7℃ (or feels hot) or <35.5℃ (or feels cold), 
lethargy or unconscious (not aroused by minimal stimulus), reduced movement 
(change in activity),not able to feed, crepitation, cyanosis and reduced capillary 
refilling time.  Each of the above signs and symptoms were associated with a 
score, the severity indicated by the increasing level of the score and the prognosis 
also depending upon the score.13           
 Powell K R (1990) described the earliest signs of sepsis as subtle and 
nonspecific; poor feeding, diminished responsiveness or just 'not looking well' 
were the earliest symptoms. More prominent finding are respiratory distress, 
apnea, lethargy, fever or hypothermia, jaundice, vomiting diarrhea and skin 
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manifestations including petechiae, abscesses and sclerema.101   
 According to data given by Gluck et al(1966), major clinical symptom and 
signs were hyperthermia 51%, jaundice 35%, respiratory distress 33%, 
hepatomegaly 33%, lethargy 25%,   vomiting 25%, abdominal distention 17%, 
hypothermia 17%, diarrhea 11%.41         
         Shasikala et al (2000), described the clinical features of sepsis and refusal 
of feeds (61%), respiratory distress (40%), convulsions(29%), abdominal 
distention(23%) were the main features in neonatal sepsis.119  
 
Diagnosis:    
 Mary C Harris et al (2007), suggested one septic screen with combination 
of diagnostic tests which improves the predictive value. That was included 
absolute neutrophil count <1,750/cmm(1point), Total WBC <7,500 or 
>40,000/cmm(1point), immmature to total neutrophil count ratio >0.2(1point) or 
>0.4(2points) and CRP levels >1.0 mg/dl(1point) or >5.0 mg/dl(2points) and the 
result considered positive when the point value was 2 or more.80     
 Yvonne R. Shea,(2011), tabled the specimens for recovery of fungal 
pathogens. Yeasts like Candida was isolated from all types of samples includes 
blood, bone marrow, CSF, eye, respiratory sites, skin, mucus membrane, urine, 
multiple systemic sites and catheter and catheter exit site. Cryptococcus 
neoformans were isolated from the entire above specimen except catheter and 
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catheter exit site. Malessazia species were isolated from blood, skin, mucus 
membrane and catheter and catheter exit site. Moulds like Aspergillus species 
isolated from brain and CSF, eye, respiratory site,  skin, mucus membrane and 
urine. Zygomycetes were recovered from CSF, eye, respiratory site,  skin and 
mucus membrane.147           
  Kyle C (2008) hand book described about the methods for the 
diagnosis of candidiasis. Budding  yeast cells might be seen in direct wet mount or 
Gram staining of urine and CSF samples and it should be correlated with that of 
the culture  growth. Blood culture was positive within 3 days after invasive 
infection. Candida isolation from normal sterile body fluids was considered as 
invasive fungal infection. Antigen or antibody detection tests were less sensitive in 
diagnosing fungal infections. Germ tube formation was a simple test used to 
differentiate C.albicans and C.dubliniensis from other candida species.73   
 
Culture: 
 A study about time to positivity of neonatal blood cultures conducted by 
Khadija Guerti et al (2010) at Belgium, was showed that the isolation of fungal 
pathogens in suspected sepsis were about 5.5% in a neonatology unit. The time to 
positivity for yeasts like candida were  40% within 24 hours, 95% within 48 hours 
and remaining took 72 hours by conventional culture methods.68    
  Arendrup MC, et al (2009), stated that positive blood culture in 
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invasive fungal infections was only about 40-60% and it was the standard method 
for diagnosis. In neonates only 0.5-1ml of blood could be withdrawn in each cases 
and this had reduced the sensitivity of the culture reports. Blood cultures were 
almost always negative in disseminated Aspergillosis.6     
 Kennaugh et al(1987), documented that common pediatric pathogens of 
neonatal sepsis might be recovered from small volume of blood (0.5ml),even when 
it cultured at blood and BHI ratio of 1:100. 67    
 Aniscough et al(1998), compared the cost effectiveness  of CHROMagar 
with SDA, and the sensitivity was increased up to 92.5% in CHROMagar. It was 
more useful in C.albicans isolation on CHROMagar media. It was one of the least 
time consuming method for presumptive diagnosis. The study suggested direct 
inoculation of specimens into CHROMagar media when yeast cells were seen in 
specimens under microscopy.5       
 There were increasing number of patient with invasive fungal infections and 
more reports were obtained about the resistance pattern to antifungal drugs. To 
reduce the antifungal drug resistant and for a better clinical outcome, Sanjay G. 
Ravenkar et al (2005) recommended antifungal susceptibility testing for all the 
isolated fungal pathogen.117         
 According to Espinel-Ingroff A et al (1998) many techniques had been 
used to determine antifungal susceptibility testing like Broth dilution, Agar based 
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methods, uptake of metabolites and flow cytometry. Agar method was easy and 
low cost method but there were wide variation of results. Broth dilution methods 
like macro broth and micro broth were widely used and it had been standardized by 
CLSI. End point determination was an important observation in broth dilution 
methods. Amphotericin B the fungicidal drug produce with distinct end point with 
complete clearance of turbidity but fungistatic drugs like azoles did not produce 
distinct end point and there was partial clearness of turbidity.31    
 Alternate testing methods described by Arthington-Skaggs et al (2002). 
Simple techniques like disk diffusion and E test and quick methods like flow 
cytometry, sterol quantization and automated system were used in some laboratory 
depending upon their feasibility.7       
 
Serological test:         
 Ellepola et al (2005) summarized numerous methods for detection of 
candida antibodies and antigens. Antibody assays had low sensitivity and low 
specificity. It could not discriminate systemic candidiasis and colonization. To 
distinguish the above condition, diagnostic markers of mannan and mannoproteins 
had been evaluated.  Galactomannan was used for the detection of invasive 
Aspergillosis.28          
 Fungus specific metabolite detection had been used as markers in fungal 
infection. Hui M, et al (2004) described the detection of D-arabinital and D-
 51  
mannital and the ratio of  D-arabinital /L arabinital by gas liquid chromatography 
or by mass spectometry.52         
 Philip and Hewitt (1980) documented that measuring the peripheral blood 
cell count and differential count was probably the most useful non-specific and 
reliable screening test. If the total count is under 5000 cells/ cmm or if the band to 
neutrophil ratio equal or exceeded to 0.2, bacterial or fungal sepsis should be 
strongly considered.98    
 According to Meharbansingh, micro-ESR estimation was a simple and 
inexpensive method  but it was not a very reliable marker of neonatal infection. A 
value of more than 15mm is considered as infection in the neonates. Estimation of 
C-reactive protein (CRP) level was the best indicator of sepsis and also useful 
marker to monitoring the effectiveness of treatment.84     
   Biomarkers like acute phase reactants (C reactive protein, 
feeritin, lactoferrin, neoptrin, procalcitonin and serum amyloidA),cytokines like 
tumor necrosis factor (TNF) alpha, Interleukins (IL) 1- alpha, 1-beta, 6,8,10,18 and 
leukocyte surface markers like CD11b,ICAM-1, CD63, CD64, CD66b were used 
as  newer diagnostic tools in some centers  and it was stated by Lever A et al 
(2007).74           
 The CRP level measured at the onset of signs of infection had an overall 
sensitivity between 35% to 94% and specificity between 60% and 90% in 
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diagnosis of sepsis as documented by  Pourcyrous et al (1993).100 
 Hanan E et al(2012) studied about CD64 expression in neonatal sepsis and 
noted that it was a useful indicator to differentiate infected from noninfected 
neonates. This test was done by flow cytometry and the cost of the test was the 
limiting factor for routine use.45       
 
Treatment : 
 Most of the fungal sepsis were treated by conventional antifungal regimes 
include amphotericin B  and its lipid formulations and fluconazole. In vitro 
resistance to this drugs, especially for C. albicans and C.parapsilosis were 2to 7% 
reported by Pappas et al (2004). Clinical treatment failure and persistence of 
infection also reported. Those patients need voriconazole and newer drug 
echinocandins for clinical cure. 95       
 Zaouits et al (2007) suggested amphotericin B treatment for systemic fungal 
infections. Lipid formulation was useful to reduce renal toxicity. Azoles like 
fluconazole and voriconazole were also used as alternate for amphotericin B. 
Combined use of flucytosine  with amphotericin B had better tissue penetration. 
Flucytocine  monotherapy might lead to resistance. After negative culture report 
for fungal growth, the antifungal treatment to should be continued for further 14 
days.150  
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 Juster-Reicher et al (2003) recommended intravenous infusion of amB 
deoxycholate at a dose of 1.0 to 1,5 mg / kg / day over 2-6 hours and liposomal 
formulation at a dose of 5 to 7 mg / kg / day over 2 hours. Addition of oral 
flucytosine 12.5 to 37.5 mg /kg / dose for every 6 hours was helpful if there was 
meningitis. Empiric antifungal was also recommended for acutely 
thrombocytopenic ELBW infants.60   
 Yang YI et al, (2003) studied about antifungal drug resistance and noted the 
susceptibility degrees of candida species  towards the  antifungal drugs varied and 
there was increased resistance to antifungal drugs.146      
 Sturat SM et al (1992) suggested temporary cessation of lipid infusions and 
removal of central venous catheter (CVP) to control the growth of  malassezia 
infection. Ampotericin B should be used for treatment until the negative blood 
culture report.132       
 Espineal-Ingroff et al (2008), stated that, in vitro antifungal susceptibility 
test were  provide a reliable measure of the relative activities of  antifungal drugs, 
correlate in vivo activity and predict the outcome, to monitor the development of 
drug resistance and predict the therapeutic potential of newer drugs. New 
developments in the standardization of in vitro antifungal susceptibility testing 
procedures become a useful aid in selecting appropriate drugs. Apart from drug in 
vitro susceptibility, host immune response, status of underlying disease, proper 
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diagnosis and management and interaction of organisms and drug inside the patient 
are also determine the outcome.30     
 Sandana et al., (1997), have evaluated the role of double volume exchange 
transfusion in septic neonates with sclerema and demonstrated a 50% reduction in 
sepsis related mortality in the treated group. That also found, non-specific pooled 
intravenous Immuno globulin not a beneficial one.115  
Prevention:    
 Mathus et al., (1990) documented that, regular antenatal check up during 
pregnancy  and increased use of prenatal care facilities might    lower  the rate of 
prematurity.  More appropriate management of prolonged interval after rupture of 
membranes, maternal post partum infections and fetal distress would  reduce the 
incidence of neonatal sepsis.81        
 Harbarth S et al (2002), suggested hand washing and degerming by alcohol 
based hand rub with emollient were the simplest and most effective methods of 
preventing transmission of infectious agents from health care personal to newborns 
based on their study in hospitals and NICUs. 49       
 The NeoIN Surveillance network in England (2011) implemented simple 
infection control methods with proven efficacy. The suggested methods by their 
surveillance study were s  promotion of clean deliveries, hand washing and barrier 
nursing, exclusive breast feeding, restriction of antibiotic use and minimizing 
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intervention and rationalization of admissions and discharges from neonatal 
units.137 
 Adams-Chapman et al,(2002) suggested important principles for the 
prevention of  nosocomial infection in NICU and that were nursery design 
engineering, Universal precautions, hand washing, meticulous skin care, 
minimizing central venous catheter contamination, early and appropriate 
advancement of enteral feeding , education and feedback for nursery personnel and 
continuous monitoring and surveillance of nosocomial infection rate in NICU.1 
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Materials and Methods 
 This study was conducted at Government Rajaji Hospital attached to the 
Madurai Medical College, Madurai. The study period was one year from 
September 2013 to September 2014.  Permission was obtained from Director, 
Institute of Child Health and Research Centre (ICH & RC),  and Professor, 
Department of  Paediatric Surgery ,GRH. A total of 200 suspected cases of 
neonatal septicaemia were included in this study. Ethical committee clearance was 
obtained before starting the study and informed consent was obtained from parent 
or guardian of each patient.         
 The samples like blood, urine and cerebrospinal fluid (CSF)  were collected 
from neonates admitted at Newborn Intensive Care Unit (NICU).   
           
Inclusion criteria 
 1.   Newborn babies more than 1 week of NICU stay.         
 2. Babies admitted with suspected septicemia.   
   3. Premature babies (37 weeks), low birth weight babies (<2500gms). 
 4. Babies on ventilator care. 
 5. H/O insertion umbilical line / Presence of central venous catheter  
 6.Use of surfactant / blood, blood products or exchange transfusion / on total 
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    parentral nutrition (TPN).       
 7. Newborn with  broad-spectrum antibiotics administration. 
 8. Neonates who underwent major surgeries. 
Exclusion Criteria : 
1. Newborns with short duration of NICU stay (<7days)      
2. Newborns admitted for observation 
3. Admitted for phototherapy 
4. Newborns with major congenital anomalies.      
5. Other healthy babies          
            
Selection of cases: 
 Newborns with above mentioned criteria were included in this study. Data 
like date and time of delivery, mode of delivery (normal, LSCS, outlet forceps and 
vacuum extraction), duration of labour, place of delivery (home, primary health 
centre (PHC), Government hospital (GH), private hospital and institutional 
delivery), transport details if any and admission time with date were recorded. 
  Infants risk factors like low birth weight, preterm, surfactant therapy, 
ventilator care, total parental nutrition (TPN), duration of hospital stay and broad 
spectrum antibiotic administration, history about umbilical catheter insertion, 
central line intravenous catheter, history about major surgical intervention, 
transfusion of blood, platelet, fresh frozen plasma (FFP) and exchange transfusion 
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were noted..          
 Investigation reports like  total count, differential count, immature cell 
count, total vs. immature cell ratio (I/T), platelet count, C-reactive protein level 
(CRP) and previous bacterial culture report if any were noted from the case records 
of the newborns                       
 
Sample Collection:86  
   Sample like  blood, CSF or urine were collected from the clinically selected 
cases for fungal culture.        
Blood:           
 Blood sample was collected under strict aseptic precautions. Approximately  
5 cm diameter of the skin over the selected site was cleaned thoroughly with 70% 
ethyl alcohol or isopropyl alcohol, followed by 10% Povidone iodine and then the 
skin was allowed to dry for at least one minute before the sample was collected. 
About 0.5- 1ml of blood was collected and it was inoculated into the Brain Heart 
Infusion (BHI) broth bottles (5 ml BHI in each bottles) for conventional culture. 
All the blood samples were collected from a peripheral vein and not from pre-
existing intravenous catheters.             
CSF:            
 Adapting strict aseptic precautions, CSF samples collected by lumbar 
puncture method (L3-L4 level of spinal card) in suspected babies. 1-2 ml of CSF 
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collected in a sterile screw capped tube. It was transported immediately to the 
laboratory for wet mount, Gram staining, India ink mount and  for culture. 
Urine:            
 Urine sample was collected aseptically by insertion of sterile urinary 
catheter or infant feeding tube and it removed immediately after the adequate 
volume of urine (10 -20 ml) collection in suspected septicemia cases of newborns.  
Urine  was collected in a sterile container and transported immediately to 
laboratory for processing.     
 
Transport and storage:         
 All the bottles or containers were checked for proper labeling and requisition 
forms were filled with necessary details of each patient.     
 All the samples were collected in a leak proof container and transported to 
the laboratory as early as possible. If there was delay in transport of sample, blood 
and CSF were kept in room temperature and urine was refrigerated at 4℃.86 
 
Processing of samples:56        
 The specimens were  processed as per protocol, depending upon nature of 
material collected in a particular case.  Universal precautions were followed during 
the processing.           
 The entire samples were examined macroscopically for the turbidity, 
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presence of fungal filaments and deposits. Sabourauds Dextrose Agar (SDA) 
medium with antibiotic supplements- gentamicin and cholramphenical  was used 
for fungal culture.            
Blood:  
 The blood samples in BHI broth was directly inoculated in to two SDA 
slopes .     
CSF: 
  If the volume was below 2ml it was directly used for processing. If it was 
above 2ml, it was concentrated by centrifugation (1500-2000 rpm for 3 minutes), 
the supernatant was removed aseptically with a sterile pipette and the sediment was  
used for processing  like direct wet mount, Gram staining, India Ink examination 
and directly inoculated in to two  SDA slopes for culture.  
Urine:  
 Urine sample was centrifuged at 2000rpm for 3 minutes. The supernatant 
was removed aseptically with a sterile pipette and the sediment was used for 
processing. It was used for direct wet mount, Gram staining and inoculated in to 
two SDA slopes for culture.        
 
Direct microscopic examination:53        
Direct wet mount:         
 1. The specimens like centrifuged CSF and Urine deposits were examined as 
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direct wet mount.            
2. A drop of the specimen (centrifuged deposit of CSF and urine) was placed on a 
clean glass slide.          
 3.It was  covered with a cover slip and observed under microscope at low 
and high power objectives. 
Gram staining:          
 Gram staining is effective for detection of some of fungal pathogens directly 
from specimen. The yeast cells are Gram-positive   in stained smear.     
 Procedure: 
 1. Smear was prepared from centrifuged CSF and urine sample.   
  2. After fixing the smear, 0.5% aqueous crystal violet solution poured over 
the slide to cover the smear and kept for 1 minute. 
 3.  It was washed gently under tap water. 
 4. Gram's iodine solution was applied over slide for 1 minute and washed 
with tap water. 
 5. It was decolorized quickly with acetone (2 to 3 sec) and washed 
immediately in water. 
 6. Counter staining was done with dilute carbol  fucshin and washed with tap 
water. 
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 7. Air or blot dry was done and examined under the oil immersion.  
     
   All fungi are Gram positive. The yeast cells usually show well stained 
morphology but filamentous fungi in smears become desiccated and their 
morphological characteristics may be lost.  
India ink preparation:         
 Permanent black fountain pen Ink was used for this test. Procedure: 
1. A drop of the specimen (centrifuged deposit of CSF, urine) was placed on a 
clean glass slide. 
2.  1-2 drops of India ink was added and mixed. The preparation should be 
brownish, not black. 
3. It was covered with a cover slip and observed under low and high power 
objectives. 
 Capsular material is exhibited by the appearance of a clear, well demarcated 
halo around the yeast cell. 
 The capsules of cryptococci vary from 2 to 10µm or more in width. 
 White cells was distinguished from Cryptococcus neoformans because of the 
irregular edge with halo and a pale cell wall in WBC. 53    
Lacto Phenol Cotton Blue (LPCB) mount: 
LPCB mount is effective for detection of fungal morphology especially in moulds. 
Procedure: 
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1. A drop of LPCB was placed on a clean glass slide. 
2. A drop of the specimen (centrifuged deposit of CSF, urine) was mixed with 
LPCB. 
3. It was covered with a cover slip and observed under the microscope with low 
and high power objectives.53 
 
Fungal culture: 55           
 Emmons' modification of Sabouraud Dextrose Agar (SDA) was used for 
culture. The media supplemented with antibiotics, such as gentamicin and 
chloramphenical.           
 1. SDA slants were prepared in a sterile screw capped bottles.    
 2. Each sample was inoculated in to two  SDA slopes and they were 
incubated at two different temperature , one  at 37℃ and another at 25℃.  
 3. The growth was observed every day for first three days, 5thday and 7th 
day of first week and then every week for four weeks duration.    
 4. When fungal growth was noted, that SDA growth was subjected for 
subculture and further processing. It was observed for entire period of four weeks 
to six weeks.        
Culture reading: 56         
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Macroscopic appearance of growth:       
 Yeast colonies were  smooth, creamy, viscous or pasty colonies and  grown 
within 24-72 hours.        
 Moulds were distinct woolly or cottony colonies and aerial mycelium were 
also noted in some of the fungal growth.      
 Rapidly growing moulds (48-72 hours) without an distinct border, 
Zygomycetes may be considered.       
 Moulds that grow within 3-5 days, had a distinct border and white, pastel on 
surface with new growth at the periphery were belongs to hyaline group of moulds.
 Slow growing (7-10 days) with a delicate or cobweb aerial mycelium usually 
gray or gray-brown in color considered as dimorphic fungi.     
Identification methods:         
 These include microscopic examination, special culture techniques, and 
specific tests for speciation, biochemical reactions and antifungal susceptibility 
testing of the isolates.         
 
Microscopic examination:        
 Direct wet mount, India ink preparation and Gram staining was done from 
the fungal growth as described above.        
 Lacto Phenol Cotton Blue (LPCB) mounts:  
LPCB mount effective for detection of fungal morphology especially in moulds. 
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 A small portion of the colony removed from the agar surface with a teasing needle 
and placed it into the drop of LPCB. The mycelial mass was teased and separated 
apart by using pairs of teasing needles. It was covered with cover slip and 
examined as described above.  
 
Colony morphology:54        
 Candida yeast cells are small oval cell with single budding and Gram 
positive. On SDA cream colored pasty colonies seen after 24-48 hours at 35-37 ℃. 
It had a distinctive yeast smell.  
    Candida growth morphology:      
S.No Species Growth on SDA   
1 C.albicans Cream colored, pasty and smooth, edges are 
radiating starburst spicules in old culture. 
2 C.tropicalis Cream to off-white, glistening to dull, soft, 
smooth or wrinkled with mycelial fringe. 
3 C. glabrata Small, glistening, smooth, cream-colored. 
4 C. krusei  Flat, dull and dry in long incubation greenish yellow, wrinkled. 
5 C.kefyr 
(pseudotropicalis) Creamy, smooth to yellowish, dull. 
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6 C. parapsilosis Creamy, lacy pattern. 
7 C. guilliermondii Creamy, smooth to yellowish, dull. 
8 C. parapsilosis Creamy, lacy pattern 
 
Speciation of candida:69          
  For identification and speciation of Candida, Germ Tube Test (GTT), 
Dalmau plate method on Corn Meal Agar (CMA), urease test, sugar fermentation 
and assimilation tests (auxanogram), were used. GTT was used for presumptive 
identification of C.albicans and C. dubliniensis. The demonstration of germ tube is 
also known as Reynolds-Braude Phenomenon. The above two also produce 
chlamydospores on CMA or Rice Meal Agar (RMA). C.dublinensis does not grow 
at 45 ℃ and does not assimilate xylose sugar. C.glabrata ferments and assimilates 
only glucose and trehalose, whereas C.tropicalis do so with sucrose and maltose. 
  Morphological features of yeast on CMA often allow tentative 
identification of  particular species. CHROMEagar Candida is a rapid plate based 
method used for simultaneous isolation and identification of various Candida 
species. This is based on the direct detection of specific enzymatic activities by 
adding certain  fluorochrome  substrate to the media.  
   
Tests used for identification of yeasts 
1. GermTubeTest56 
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 A germ tube is defined as a filamentous extension from a yeast cell that is 
about half the width and three to four times length of mother cell. It is a hyphal 
structure and there is no constriction at the neck.      
1. In a sterile test tube, 0.5 ml of human serum was taken.    
2. With a sterile loop, small portion of yeast colony was inoculated into the serum. 
3. It was incubated at 37 ℃. for 2-3hours. 
4. After incubation, wet mount was prepared from that suspension.   
5. It was observed under low and high power objectives of a microscope.  
Candida albicans and C.dubliniensis produce germ tube. 
  Germ tubes are the beginnings of true hyphae and appear as filaments that 
are NOT constricted at their points of origin from the parent cell. If the filaments 
are constricted and septate at their points of origin they were considered as 
pseudohyphae, not germ tubes.  
 
2. DALMAU PLATE(Corn meal agar) morphology: 35 
 Corn Meal Agar with tween 80 was used to differentiate species of Candida.    
 With a sterile loop, small portion of yeast colony was inoculated vertically 
on to CMA as a streak line without cutting the agar. Then 3 to 4 streak lines were 
made across the first inoculation to dilute the first inoculam. The streak lines were 
covered with a 22 by 22mm cover slip. It was incubated at room temperature in the 
 69  
dark for 24-48 hours. The growth was examined microscopically after removing 
the lid and placing the culture plate directly under the low and high power 
objectives. An isolate of C.albicans was included as a positive control. 
  DALMAU PLATE (Corn meal agar) morphology:  
S.No Species Morphology on Cut-streak (Corn Meal) agar 
(DALMAU PLATE) 
1 C.albicans Irregular or spherical clusters of blastospores at septa. 
Numerous chlamydospores single or in clusters, 
Terminal chlamydospores. 
2 C.tropicalis Blastospores anywhere along mycelium or in 
irregular clusters. Chlamydospores very rare 
3 C. glabrata Very elongate cells which readily fall apart and lie 
parallel. "Logs in stream" appearance, not produce 
pseudohypha 
4 C. krusei  Elongate cells forming a branched mycelium easily disintegrated. "Crossed sticks" of septa. 
5 C.kefyr 
(pseudotropicalis) Very elongated cells, abundance of pseudohyphae 
6 C. parapsilosis Fine and coarse mycelium (giant forms). Blastospores 
single or in short chains at septa or distal ends of cells 
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7 C. guilliermondii Very fine mycelium. Small clusters of blastospores at 
the septa 
8 C.dubliniensis Irregular or spherical clusters of blastospores at septa. 
Numerous chlamydospores single or in clusters, 
             
3.Sugar fermentation tests: 147         
 It is a method used for identification of yeasts by the ability to ferment 
various sugars.           
 1. Fermentation test media was prepared by using sugars like like glucose, 
sucrose, lactose and maltose, galactose and trehalose  in a sterile test tube with 
inverted Durham's tube.         
 2.  Heavy inoculam of yeast colony grown on sugar free media was used for 
preparation of suspension.         
 3. Each carbohydrate broth was inoculated with approximately 0.1 ml of 
above suspension.          
 4. All test tubes were incubated at room temperature up to one week. 
 5. The tubes were examined daily for production of acid (yellow color) and 
gas in Durham's tube.         
 6. Production of acid and gas was taken as fermentation reaction and only 
acid production indicates the assimilation. 
    Interpretation of fermentation tests:  
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S.No Species Glu Mal Suc Lac Gal Tre 
1 C.albicans AG AG A - AG AG 
2 C.tropicalis AG AG AG - AG AG 
3 C. glabrata AG - - - - AG 
4 C. krusei AG - - - - - 
5 C.kefyr 
(pseudotropicalis) AG - AG AG AG - 
6 C. parapsilosis AG - - - - - 
7 C. guilliermondii AG - AG - AG AG 
8 C.dudliniensis AG AG - = AG AG 
Note: Glu = Glucose, Mal = Maltose, Suc = Sucrose, Lac =Lactose, Gal = 
Galactose, Tre = Trehalose, A = Acid Production, G = Gas Production. 
 
4. Sugar assimilation tests:148    
(Auxanographic plate method - Haley & Standard modification):  
 1. Yeast suspension was prepared by mixing of yeast colonies in 6 ml of 
distilled water. The turbidity was matched with No 4 Mcfarland standard 
 2. Yeast nitrogen base medium was prepared and allowed to decrease the 
temperature to 50℃.         
 3. Two sterile disposable petri dishes were labeled with number of each 
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isolate and the names of sugars used (6 sugars per plates).   
 4. Three ml of yeast suspension and 15ml of yeast nitrogen agar base poured 
to the above petri dishes and mixed well.       
 5. It was allowed to settle at room temperature. 
 6. Carbohydrate solution (20%) was prepared separately for each sugar. 
 7. Sterile discs were made from Whatman No1 filter paper. 6 discs were 
placed over the agar medium of each plate.      
 8. By using a 2 mm sterile loop, 20% carbohydrate solution was placed over 
the discs in the designated areas. 
 9. The plates were incubated for 24 hours at room temperature. 
         10. The plates were observed for growth of yeast colonies around the discs. If 
there was growth around particular sugar disc, then that sugar was taken as 
assimilated.           
 The sugars used for assimilation test were:  Glucose, Maltose, Sucrose, 
Lactose, Cellobiose, Galactose, Trehalose, Raffinose, Melibiose, Xylose, Inositol 
and Dulcitol.  
 
5. Kit based Sugar assimilation tests: 
 This test was done by using a standardized colorimetric identification kit 
with 12 conventional biochemical tests. Eleven tests for sugar assimilation and 
one for urea hydrolysis. HiCandida Identification Kit obtained from HiMedia 
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laboratories Pvt. Limited, Mumbai. The tests were based on the principle of pH 
change and substrate utilization. Growth  of a particular species produced 
metabolic changes which were indicated by a spontaneous color change in the 
media.      
Procedure:           
1. A single fresh yeast colonies (24-48 hours) from SDA was inoculated into 5 ml 
of Potato Dextrose Broth (PDB).         
2. It was incubated at 22-25 ℃ for 6-8 hours and turbidity was matched to 0.5 
McFarland standards (1 ✗ 10  to 5 ✗ 10  CFU/ml).      
3. Under aseptic condition, the test strip was opened. Lab ID Number was marked 
at a corner.             
4. There were 12 test wells in one kit. Each well of the strip was inoculated with a 
loopeful of inoculum from PDB tubes by stabbing.      
5.  Then it was incubated at 22-25℃ for 24 to 48 hours.      
6. Test results were interpreted after 24-48 hours, yellow indicated positive 
reaction and orange indicated negative reaction, pink color change in urease test 
well indicated hydrolysis of urea.          
Sugar assimilation test done by conventional and kit based method  were 
compared, the results were same.      
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Interpretation of assimilation tests:  
S. 
No Species Glu Mal Suc Lac Gal Mel Cel  Ino Xyl Raf Tre Dul 
1 C.albicans + + + - + - - - + - + - 
2 C.tropicalis + + + - + - + - + - + - 
3 C.glabrata + + - - - - - - - - + - 
4 C.krusei + - - - - - - - - - - - 
5 C.parapsilosis + + + - + - - - + - + - 
6 C.guillermondi + + + - + + + - + + + + 
7 C.kefyr + - + + + - + - + + - - 
8 C.dubliniensis + + + - + - - - + - + - 
  
Note: Glu = Glucose, Mal = Maltose, Suc = Sucrose, Lac =Lactose, Cel = 
Cellobiose, Gal = Galactose, Tre = Trehalose,  Raf = Raffinose,  Mel = Melibiose, 
Xyl = Xylose, Ino = Inositol, Dul = Dulcitol; + = Positive Reaction, - = Negative 
Reaction,   V = Variation.        
 
6.Urea hydrolysis 56 
 This test was used to detect the urease enzyme production ability of yeasts. 
The yeast colony was inoculated on slants of Christensen's urea agar and incubated 
at 25-30℃. Urease enzyme splits urea into ammonia  which raises the PH of the 
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medium  and changes the color of the  phenol red indicator to pink color.  Positive 
test was indicated by change in color to deep pink within 2-5 days. All of the 
Candida species give negative results except C.krusei.  
 
7.CHROMagar Candida29         
  CHROMagar test media was a selective and differential chromogenic 
medium. The test was based on direct detection of specific enzymatic activities of 
different Candida species. This CHROMagar test media contains substrate of 
flourochrome dyes which produce different colors for different species of Candida 
growth to the media. Media was brought from HiMedia laboratories Pvt. Limited, 
Mumbai ( HiCHROM Candida Differential Agar).  
Procedure:           
 Yeast suspension was prepared from fresh colonies of Candida growth. It 
was inoculated to CHROMagar media by streak culture method and incubated at 
room temperature .The plates were observed everyday up to one week for color 
production.     
  
Interpretation of CHROMagar Candida medium growth color:   
 C.albicans:          Light green to Bluish green     
 C.tropicalis:        Blue with pink halo       
 C.glabrata:          Pink to purple, glorry      
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 C.krusei:              Spreading pink       
 C.kefer :               White        
 C.parapsilosis :    Cream/off-white 
 C.guilliermondii: White to cream 
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Yeast Identification Scheme: 
 














    +     - 
 
             
             
Pure yeast isolate 
Germ tube test sugar assimilation sugar fermentation Morphology on Corn Meal agar (CMA) LCB & CMA 
Yeast only Yeast + Pseudohyphae+ Chlamydospores  Germ  Tube Yeast + Pseudohyphae 
- 
+ 
C.albicans &    C. dubliniensis Candida Cryptococcus  Terminal chlamydospores  Sugar fermentation & assimilation test for identification of yeast 
Candida spp 
Urease test 
Cryptococcus Multiple in bunches: C dublinensis Single: C albicans Candida 
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  ANTIFUNGAL SUSEPTIBILITY TESTING METHODS  
   Methods used for antifungal susceptibility testing    
S.No Test method Endpoint detection 
1 Broth macrodilution  Visual comparison of turbidity (⪰50% inhibition)  
2 Broth microdilution    Visual comparison of turbidity (⪰50% inhibition)   
3 Agar dilution Visual comparison of growth 
4 Disk Diffusion Zone diameter. 
              
1.Macro broth and Micro broth Dilution antifungal susceptibility Testing106 
Purpose 
 Antifungal susceptibility testing is conducted to determine the minimum 
concentration of antifungal drug required to inhibit growth of fungal isolates. The 
macro broth dilution method was the first standardized method but it was very 
labor intensive. This led to the development of the Microtitre method. Microtitre 
wells are inoculated with a standardized inoculum from nutrient broth suspension 
(RPMI1640 for fungi) in columns 1-11 while columns 12 acts as the media 
negative control. The primary advantage of such broth dilution tests is that it 
permits several organisms to be tested per plate. 
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Clinical significance: 
 Antifungal susceptibility testing assists the physician in making therapeutic 
decisions. It is also useful in identifying potential reasons for therapeutic failure. 
 All yeast isolates must be streaked for isolation onto Potato Dextrose agar 
(PDA). Subculture yeast to PDA agar quadrants and incubate at 30°c for 24-72 
hours prior to testing.  
 CLSI M27-A3 document broth dilution guidelines for antifungal 
susceptibility testing of yeasts. 
 
Procedure:          
 1.Broth medium was RPMI 1640 broth buffered with MOPS buffer (0.165 
M) and 0.2% dextrose and glutamine without sodium bicarbonate to a pH of 7.0.  
Media was brought from HiMedia laboratories Pvt. Limited, Mumbai   
 2. Inoculum was prepared from the fresh growth on Potato Dextrose agar 
(PDA).  Five colonies were picked from PDA and mixed well into RPMI medium. 
 3. Stock inoculum suspension adjusted to match the turbidity of a 0.5 
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A dilution of 1:2000made from 
stock inoculum suspension; 
inoculum size after inoculum, 
0.5✗ 10³ to 2.5✗ 10³ CFU/ml. 
A dilution of 1:1000made 
from stock inoculum 
suspension; inoculum size 
after inoculum, 0.5✗ 10³ to 
2.5✗ 10³ CFU/ml. 
Drug 
dilution Done by adding drug with additive    (DMSO) 10 ✗  dilutions for 
Fluconazole and drug with solvent 
(DMSO) 100 ✗ dilution for 
Amphotericin B. 
Done by adding drug with 
additive ( DMSO) 2 ✗  
dilutions for Fluconazole and 
drug with solvent (DMSO) 






Drug dilution ranges were for  
fluconazole 0.12-64 µg/ml and for 
amphotericin B 0.03-16 µg/ml 
Drug dilution ranges were 
for  fluconazole 0.12-64 
µg/ml and for amphotericin 
B 0.03-16 µg/ml 
  Drug and 
inoculam 
mixing 
0.1 ml of drug and 0.9 ml of 
inoculam added to small sterile test 
tubes. 10 tubes for different drug 
100µl of drug and100µl of 
inoculum added to microtitre 
well. 10 wells for different 
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range ,11th tube for inoculam 
control and 12th one for media 
control . 
drug range ,11th well for 
inoculam control and 12th 
one for media control. 
Reading and interpretation:         
 All tubes or microtitter wells were incubated at room temperature.  
 Time of  reading for Amphotericin B, 24 or 48 hours and for fluconazole 48 
hours.             
 MIC by visual examination measured for Amphotericin  B as lowest drug 
concentration that prevents complete growth (100% inhibition).  MIC by 
visual examination measured for Fluconazole as lowest drug concentration that 
shows prominent (~50%) decrease in turbidity. 
Agar dilution method: 22        
Medium:           
 Agar dilution method was performed on SDA plates supplemented with 
gentamicin and chloramphenical.         
Procedure and interpretation:         
1. Drug dilution done by adding drug with additive (DMSO) 10 ✗ dilutions for 
Fluconazole and drug with solvent (DMSO) 100 ✗ dilution for Amphotericin B.  
2. From each range of drug dilution 2 ml was taken and added to 18 ml of molten 
SDA and then poured into petri dishes and allowed to settle.    
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3. The SDA plates were divided into 9 columns by using marker pen and 8 
columns were used for test organism and 9th one for sterility control.   
4. 10µl of standardized inoculum was added to the corresponding column. About 8 
isolates were taken for each test and that inoculated to 8 columns and 9th column 
was kept uninoculated.          
5. Plates were incubated at room temperature for 24 hours.    
6. All the plates were inspected macroscopically for the presence of growth.   
7. Lowest concentration of the drug which prevented growth was taken for MIC.    
Interpreting Results:- 
Antifungal 




ble S-DD Resistant  
Amphoteri





24hrs   
≤1.0 
µg/ml - >1.0 µg/ml 
Fluconazo
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C.glabrata 
C.glabrata 24hrs 





Note: C.kursei - intrinsic resistance to fluconazole.      
 S-DD - Susceptible Dose Dependent.      
Disk diffusion susceptibility testing :21    
 CLSI M44-A2 document guidelines for antifungal disk diffusion 
susceptibility testing of Candida species.     
Procedure and interpretation:        
 1.  Agar medium used was Mueller-Hinton agar + 2% dextrose and 0.5 µg of 
methylene blue dye/ml 
 2.  Inoculum preparation done by picking up five colonies from 24-h growth  
(Candida spp.) on potato dextrose agar       
 3. Test inoculum  was prepared from stock inoculum suspension, adjusted by 
spectrophotometer at 530 nm to match the turbidity of a 0.5 McFarland standard 
which was equal to 1 ✗ 10⁶ to 5 ✗ 10⁶CFU/ml 
 4.Test inoculmn was inoculated on to agar medium by pour plate method. 
 5.Disks used with contents of  Fluconazole 25 mcg; Itraconazole 10mcg; 
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  Voriconazole 1mcg, Amphoteracin B 20 mcg and Nystatin 50mcg. 
 5.All the 5 discs were placed on to agar medium and incubated for 20-24 h 
at room temperature. 
  6.  Zone diameter was measured as the nearest point at which there was 
prominent reduction in growth. Pinpoint micro colonies at the zone edge or 
colonies within the zone should be considered as sensitive.  
Zone size interpretative chart          
 (Mueller-Hinton agar + 2% dextrose and 0.5 µg of methylene blue dye/ml) 
Antifungal agent Disc content Zone diameter, Nearest Whole (mm) 
Resistant 
mm or less S-DD Sensitive mm or more 
Amphotericin B 20mcg 9 10-17 17 
Fluconazole 25mcg 14 15-18 19 
Itraconazole 10mcg 15 16-20 21 
Voriconazole 1mcg 13 14-16 17 
Nystatin 50mcg 18 19-23 23 
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     Yeast growth in SDA 
 
     Yeast growth in PDA 
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    Yeast cells in Gram stain 
 
    Yeast cells in LPCB mount  
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    Germ Tube Test- pseudohyphea    
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   Corn Meal Agar morphology observation 
 
  C.albicans- Blastoconidium and Chlamydospore (terminal) 
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C.kefyr- long, thin pseudohyphae and blastoconidia 
 
C.tropicalis -oval or elongated blastoconidia and long pseudohyphae 
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C.guillermondii - ovoid blastoconidia and short, slender pseudohyphae 
 
CHROMEAgar growth - color production of different specis 
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CHROMEAgar growth - C.albicans: Light green to Bluish green  
 
CHROMEAgar growth- C.glabrata: Pink to purple 
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Sugar fermentation test- C.albicans 
            
 Sugar fermentation test- C.kefyr 
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Sugar assimilation test- Yeast Nitrogen Base with Sugar discs 
 
Sugar assimilation test- kit based rapid test- C.albicans 
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Sugar assimilation test- kit based rapid test- C.guillermondi 
 
Disk diffusion susceptibility testing 
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Macro broth Dilution antifungal susceptibility Testing -Amphotericin B 
 
Macro broth Dilution antifungal susceptibility Testing  -Fluconazole 
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Agar dilution method- Amphotericin B 
 
Agar dilution method- Fluconazole 
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Micro broth Dilution antifungal susceptibility Testing -Amphotericin  
 
Micro broth Dilution antifungal susceptibility Testing  -Fluconazole 
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RESULTS 
 In this study, 200 neonatal cases were selected from NICU, Institute of Child 
Health & Research Centre, GRH, and Madurai. The age group of neonates was 
those who admitted before 28 days of life. 
 On analyzing 200 cases of neonates, the sex distribution of selected cases 
was found to be male 99 (49.5%) and female 101 (50.5%). Distribution  of cases in 
relation to sex given in Table. 1.         
  Table 1: Sex wise distribution of 200 selected cases.(Fig:1) 
Gender No. of cases Percentage 
Male 99 49.5% 
Female 101 50.5% 
Total 200 100% 
 
The cases were further analyzed by admitted ward. Cases selected from 
Inborn ward (institutional delivery babies admitting unit-NICU) was 94(47%), 
from Sick Neonatal Nursery- SNN (sick labour theatre delivered babies, referral 
cases or post natal ward neonate admitting unit) was 97(48.5%) and from Pediatric 
Surgery Unit (PSU) was 9(4.5%). Distribution of cases in relation to ward is given 
in Table. 2             
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Table 2:  Distribution of cases in relation to ward.(Fig:2) 
Ward No of Cases Percentage 
NICU 94 47% 
SNN 97 48.5% 
PSU 9 4.5% 
Total 200 100% 
 The above cases were further  analysed by their birth weight. There 
were 40(20%) cases of normal weight (N >2.5kg), 111(55.5%) cases of low birth 
weight (LBW <2.5 kg), 41(20.5%) cases of very low birth (VLBW <1.5 kg) and 
8(4%) cases of  Extremely low birth (ELBW <1.0 kg). Distribution  of cases in 
relation to birth weight given in Table. 3.       
 Table 3: Distribution  of cases in relation to birth weight. (Fig:3) 
Birth weight No of Cases Percentage 
Normal 40 20% 
LBW 111 55.5% 
VLBW 41 20.5% 
ELBW 8 4% 
Total 200 100% 
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  Maturity at birth of each neonates were categorized into term and 
preterm (below 37 weeks). Term neonates were 85(42.5%) and preterm neonates 
were 115(47.5). Among the 115 preterm babies, 31(15.5%) cases were late preterm 
(>34 weeks), 62(31%) cases were preterm between 30-34 weeks and 22(11%) 
cases preterm below 30 weeks.          
 Table 4: Distribution  of cases in relation to maturity. (Fig:4) 
Maturity No of cases Percentage 
Term 85 42.5% 
Preterm 34-37 weeks 31 15.5% 
Preterm between 30-34 weeks 62 31% 
Preterm below 30 weeks 22 11% 
Total 200 100% 
 Various categories of risk factors were analyzed in this study. About 78 
(39%) cases had stayed more than 7 days in wards at the time of sample collection. 
Preterm with VLBW and ELBW, sepsis proven by bacterial culture and post 
operative neonates were mainly kept in the ward for prolonged duration.   
 Mechanical ventilator support was given for 47 (28.5%) cases. All the 
neonates who received surfactant therapy were put on ventilator. Neonates with 
respiratory Distress syndrome (RDS), with severe sepsis and some cases of post 
operative care were supported with mechanical ventilation.    
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  Umbilical catheter was inserted to 13 (6.5%) neonates, who 
underwent exchange blood transfusion and it was done for neonatal jaundice. No 
neonate had  central venous catheter insertion.      
 Surfactant therapy was administered for 20(10%) cases, mostly to the 
VLBW and ELBW neonates.       
 Among the 200 selected cases 45(22.5%) cases were transfused with blood 
Fresh Frozen Plasma (FFP) and platelet. Apart from exchange blood transfusion 
for jaundice ,all other  transfusions were received by most of the neonatal sepsis 
babies as a therapeutic measure.TPN was not used for any of the cases.   
 Antibiotics were started initially to all the admitted babies; it was 
continued beyond 5 days for suspected sepsis or proven sepsis cases and post 
operative neonates. Out of the200 selected neonates , 87(43.5) cases received 
broad spectrum antibiotics beyond 5 days.       
  About 9 cases (4.5%) underwent major surgical intervention and they 
were in post operative care.           
  Table 5: Risk factors among selected cases(Fig:5) 
S. No Risk factors Number of cases 
1. Hospital stay > 7 days 78 
2. Mechanical ventilation support 47 
3. H/O umbilical line insertion 13 
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4. Surfactant therapy 20 
5 H/O Blood transfusion 43 
6. Broad spectrum antibiotics 
administration for 5 days 87 
7. Underwent major surgery 9 
   
  Sepsis screening were  noted down at the time of sample collection. 
Total WBC count, I/T ratio, platelet count and CRP were routinely done for 
suspected neonatal sepsis cases. The results were analyzed and this is 
tabulated in table - 6.    
    
   Table 6:  Sepsis screening reports. (Fig:6) 
S. No Parameters Number of positive cases 
1. WBC count <7500 or >40000 cells/cmm 44 
2. I/T ratio >0.2 133 
3. Platelet count < 1,00,000 cells/cmm 45 
4. CRP positive 130 
 There were 103 (51.5%) culture proven cases for bacterial sepsis, among 
the screened neonates. Among that, 37 cases were EOS and 66 cases were LOS. 
  Sample like blood 179 (89.5%), CSF 11(5.5%) or urine 10 (5%) were 
collected from all  selected cases.        
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Table 7:Distribution of types of sample. (Fig:7) 
S. No Type of sample No of samples Percentage 
1. Blood 179 89.5% 
2. CSF 11 5.5% 
3. Urine 10 5% 
4. Total 200 100% 
  
 Out of 11 samples only one CSF sample showed presences of yeast cells in 
wet mount  and Gram  staining . India ink preparation did not show capsular 
structure from any of the CSF samples.  
 Out of 200 samples inoculated on to SDA, 13 samples showed growth. In 
that 12 were from blood sample  and 1 from CSF sample. All urine samples were 
culture negative for fungus.          
 Table 8: Distribution  of observed positive fungal growth. (Fig:8)  
S. No Type of sample No of samples 
inoculated to SDA Positive fungal growth observed 
1. Blood 179 12 
2. CSF 11 1 
3. Urine 10 0 
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4. Total 200 13 
  On macroscopic observation, all the 13 growth were cream colored, 
mucoid and pasty colonies. On microscopic observation of the growth by the wet 
mount preparation, Gram staining and LPCB mount showed budding yeast cells 
which was Gram positive. In India ink preparation no capsular structure was 
demonstrated from any of the growth. From the above methods, all of the growths 
were identified presumptively as Candida species. 
Speciation of candida : 
   
 Germ tube test were positive in 4 isolates out of 13 growths. All this 
isolates were reinoculated in SDA and incubated at 45℃ for further speciation. 
After 24-48hrs growth were  observed in 3 isolates, which were marked as 
C.albicans and no growth in one isolate which was C.dubliniensis.    
  
 The growth morphology of all isolates in Corn meal agar was examined 
under microscope for the formation of blastoconidia, chlamydospore and their 
arrangement and for the production of pseudohyphae. The above observations were 
compared with growth patterns described for Candida species.    
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 In CHROMEagar, color production of each candida species  were noted 
and according to the color, species of Candida were identified. Speciation  of  
candida done by special methods is given in Table 9. 
  
 Biochemical reactions like sugar fermentation and sugar assimilation were 
done and results were tabulated in table No 10.       
  
 From above special methods and biochemical test, all 13 isolates of 
candida were differentiated to species level, as C.albicans 3 in number, 
C.guilliermondii 3 in number, C.glabrata 2 in number  and C.parapsilosis, 
C.dubliniensis, C.tropicalis, C.krusei,  C.kefyr each one in number. In that 12 were 
isolated from blood samples and one C.albicans was from CSF. Species level 
distribution of Candida is given in table 11. 
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Table 9: Speciation  by special methods. 
Candida 
species 
GTT Growth at 
45℃ 
CMA morphology CHROMEagar 
growth 
Isolate No 
C.albicans + + Irregular or spherical clusters of  blastospores at 
septa. Numerous chlamydospores single or in 
clusters, Terminal chlamydospores 




C.parapsilosis - - Fine and coarse mycelium (gaint forms). 
Blastospores single or in short chains at septa or 




C.dubliniensis + - Irregular or spherical clusters of blastospores at 





C.glabrata - - Very elongate cells which readily fall apart and 
lie parallel. "Logs in stream" appearance, not 
Pink to purple, 
glorry 
C-5, C-13 




- - Very fine mycelium. Small clusters of  
blastospores at the septa 
White to cream C-7 C-11, 
C-12 
C.tropicalis - - Blastospores anywhere along mycelium or in 
irregular clusters. Chlamydospores very rare 
Blue with pink 
halo 
C-8 
C.krusei - - Elongate cells forming a branched mycelium 
easily disintegrated. "Crossed sticks" of septa. 
Spreading pink C-9 
C.kefyr - - Very elongated cells, abundance of 
pseudohyphae 
White  C-10 
GTT- Germ Tube Test, CMA - Corn Meal Agar, + = Positive Reaction, - = Negative Reaction. 
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Table No 10: Biochemical reactions - sugar fermentation and sugar assimilation 
Candida 
species  



































C.albicans + + + - + - - - + - + - AG AG A - A
G 




+ + + - + - - - + - + - AG - - - - - C-2 
C.dublinien
sis 
+ + + - + - - - + - + - AG AG - - A
G 
AG C-3 
C.glabrata + + - - - - - - - - + - AG - - - - AG C-5, C-13 
C.guillermo
ndi 
+ + + - + + + - + + + + AG - AG - A
G 
AG C-7 C-11, 
C-12 
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C.tropicalis + + + - + - + - + - + - AG AG AG - A
G 
AG C-8 
C.krusei + - - - - - - - - - - - AG - - - - - C-9 
C.kefyr + - + + + - + - + + - - AG - AG AG A
G 
- C-10 
Notes : Glu = Glucose, Mal = Maltose, Suc = Sucrose, Lac =Lactose, Cel = Cellobiose, Gal = Galactose, Tre = 
Trehalose,  Raf = Raffinose,  Mel = Melibiose, Xyl = Xylose, Ino = Inositol, Dul = Dulcitol; + = Positive Reaction, 
- = Negative Reaction,   V = Variation, A = Acid Production, G = Gas Production. 
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           Table 11: Species level distribution of Candida(Fig:9)  
S.No Name of the species Number of  isolates Percentage 
1 C.albicans 3 23% 
2 C.guillermondi 3 23% 
3 C.glabrata 2 16% 
4 C.krusei 1 7.6% 
5 C.parapsilosis 1 7.6% 
6 C.tropicalis 1 7.6% 
7 C.kefyr 1 7.6% 
8 C.dubliniensis 1 7.6% 
 Total 13 100% 
   
 Table 12: Sex wise  distribution of fungal sepsis cases. (Fig:10) 
S. No Sex No of Fungal Sepsis Cases Percentage 
1 Male 7 54% 
2 Female 6 46% 
3 Total 13 100% 
 Out of 13  fungal pathogen 7(54%) were recovered from male neonates.. 
Remaining 6(46%) were female neonates.       
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 Fungal sepsis neonates were analyzed according to place of birth  Among  
13 cases, 8 (62%) were  out born cases. Distribution  of positive cases in relation to 
place of birth is given in Table 13. 
  
 Table 13: Distribution  of positive cases in relation to place of birth. (Fig:11) 
S. No Place of birth No. of Fungal Sepsis Cases Percentage 
1 Inborn 5 38% 
2 Outborn 8 62% 
3 Total 13 100% 
  
 Low birth weight neonates showed higher incidence of infection than 
normal birth weight neonates. A total of 10 cases of LBW were affected by  fungal 
sepsis and  in that 5 of them were VLBW and 1 was ELBW neonates.   
 
Table 14.  Distribution of positive cases in relation to birth weight. (Fig:12) 
S. No Birth Weight No. of Fungal Sepsis cases Percentage 
1 Normal 3 23% 
2 LBW <2500gms 4 31% 
3 VLBW <1500gms 5 38.4% 
4 ELBW 1 7.6% 
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 There were more incidence of  sepsis  in preterm neonates. About 9 cases 
were in preterm category. Among that, one was < 30 weeks of gestational age  and 
three were late preterm > 34 weeks.          
 
Table 15:  Distribution of fungal sepsis cases in relation to maturity.(Fig:13) 
S. No Maturity No. of Fungal 
Sepsis cases Percentage 
1 Term 4 31% 
2 Preterm >34 weeks 3 23% 
3 Preterm between 30-34 weeks 5 38.4% 
4 Preterm below 30 weeks 1 7.6% 
  
 Risk factors among fungal sepsis neonates were analyzed and tabulated in 
table No. 16.  
  
 Septic screening reports which was noted down at the time of sample 
collection was correlated with positive cases. There were 10 cases with reduced 
platelet count < 100000 cells/cmm and 9 cases of  total count < 7500 cells/cmm.  
I/T ratio more than 0.3 and  raised CRP positive above 1.0 mg / dl were seen in all 
13 reports.            
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Table 16: Risk factors associated with fungal sepsis cases.(Fig:14) 
S. 
No Risk factors Number of cases associated with fungal sepsis 
1. Hospital stay > 7 days 7 
2. Mechanical ventilation support 6 
3. H/O umbilical line insertion 1 
4. Surfactant therapy 1 
5. Broad spectrum antibiotics administration 
for more than 5 days 8 
  
 Table 17:Sepsis screening reports associated with fungal sepsis.(Fig:15)  
S. 
No Parameters Number of cases associated with fungal sepsis Percentage 
1. WBC count <7500 or >40000 
cells/cmm 9 69% 
2. I/T ratio >0.3 13 100% 
3. Platelet count < 1,00,000 
cells/cmm 10 77% 
4. CRP positive above 1.0 mg / dl 13 100% 
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 Out of  200 cases, 103 cases were positive for bacterial culture and they 
were treated with broad spectrum antibiotics.  Among the 103 cases 10 cases 
showed fungal growth from their samples. According to onset of sepsis, 37 were 
noted as EOS and 66 were LOS. Of the 10 fungal positive cases, 3 were from EOS 
and 7 were LOS. This increased incident in fungal sepsis among LOS cases might  
be due to prolonged hospital stay and prolonged antibiotic treatment.     
Table 18: Distribution of fungal sepsis cases in relation to culture proven for 
bacterial sepsis cases           
S. No Culture proven for bacterial sepsis cases No. of Fungal Sepsis cases 
1. EOS 37 (36%) 3 (2.7%) 
2. LOS 66 (64%) 7 (6.7%) 
3. Total 103 (100%) 10 (9.4%) 
  Antifungal susceptibility testing was done for isolated fungal 
pathogen. The methods adapted for antifungal susceptibility  testing were Macro 
broth and Micro broth Dilution method, Agar dilution method and disk diffusion 
method. For the first three methods only Amphotericin B and Fluconazole were 
used. For disk diffusion method Itraconazole, Voriconazole and Nystatin were also 
tested. The results were observed as per standard guidelines given by CLSI.  
     Antifungal  susceptibility test interpretation results given 
in table No.19. 
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Table No 19: Interpretation of antifungal susceptibility. 
S. 
No 
Candida species Macro broth dilution, Micro 
broth dilution and Agar 
dilution method  
Disk diffusion method 





I ZD I ZD I ZD I ZD I ZD I 
C1 C.albicans 0.25  S 64 R 10 SDD 26 S 14 SDD 36 S 22 S 
C2 C.parapsilsis 0.125 S 4 SDD 17 S 15 SDD 16 SDD 34 S 27 S 
C3 C.dubliniensis 1.0 S 2 S 15 SDD 17 SDD 16 SDD 27 S 20 SDD 
C4 C.albicans 16 R 64 R 9 R 13 R 12 R 14 SDD 25 S 
C5 C.glabrata 0.125 S 64 R 10 S 8 R 26 S 31 S 19 SDD 
C6 C.albicans 0.5 S 1.0 S 14 SDD 24 S 16 SDD 35 S 16 R 
C7 C.guillermondi 0.25 S 0.5 S 17 S 20 S 16 SDD 25 S 25 S 
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C8 C.tropicalis 2 R 64 R 8 R 8 R 11 R 27 S 13 R 
C9 C.krusei 16 R - - 9 R - - - - - - 22 S 
C10 C.kefyr 0.25 S 64 R 17 S 9 R 12 R 37 S 29 S 
C11 C.guillermondi 0.25 S 0.25 S 18 S 25 S 17 S 40 S 29 S 
C12 C.guillermondi 0.5 S 1.0 S 20 S 26 S 14 SDD 36 S 28 S 
C13 C.glabrata 1.0 S 8 S 10 SDD 20 S 22 S 37 S 26 S 
        MIC- Minimum Inhibitory Concentration, ZD- Zone Diameter in millimeter, I - Interpretation,  S - sensitive,  
R - Resistant, S-DD -Susceptible Dose Dependent, AMB- Amphotericin B, FLU- Fluconazole, ITR- Itraconazole, 
VOR-Voriconazole, NYS-Nystatin.  
 Susceptible Dose Dependent was taken as sensitive. 
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  Table No 20: Antifungal susceptibility pattern.(Fig:16)  
S. 
NO Antifungal agents Number of  isolates tested Sensitive(%) Resistant(%) 
1 Amphotericin B 13 10(77%) 3(23%) 
2 Fluconazole 12 8(70%) 4(30%) 
3 Itraconazole 12 10(83%) 2(17%) 
4 Voriconazole 12 12(100%) 0 
5 Nystatin 13 11(85%) 2(15%) 
 Analyzing the Antifungal susceptibility pattern, Amphotericin B resistance 
was noticed in three isolates (23%) and remaining 10 (77%) isolates were 
susceptible. Out of 3, one C.albicans was resistant to Amphotericin B and 
C.tropicalis, C.krusei also resistant to Amphotericin B. Azole drugs tested only in 
12 isolates as C.kursei have intrinsic resistance to Azoles.  Fluconazole  resistance 
was noticed in 4 isolates(30%). One C.glabrata and  one C.albicans, C.tropicalis 
and C.kefyr  showed resistance to fluconazole.  Itraconazole  resistance was 
noticed in 2 isolates (17%).One was  C.albicans and other one was C.tropicalis. All 
12 Candida species(100%) were sensitive for voriconazole and  among them one 
C.albicans was in Susceptible Dose Dependent (SDD) range. SDD was taken as 
sensitive. For Nystatin 11(85%) out of 13 isolates 11 were sensitive, among them 2 
were SDD and 2 were resistant.    
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Figure 5: 
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Figure 15: 
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Discussion 
 
 Neonatal sepsis is one of the leading causes of neonatal mortality and 
morbidity. Now a days, fungal pathogens are emerging as important causative 
agents. The severity of fungal sepsis is more than any other infections. The 
antifungal drug resistance is also being reported. Most vulnerable group for fungal 
sepsis is neonates, because of their immature immune system and this is one of the 
cause for increasing neonatal mortality rate. And so, there is a need for evaluation 
of fungal sepsis in neonates. This study is designed to carry out such evaluation in 
neonates.            
 In this study the incidence of fungal sepsis in neonates was 6.5%. This is in 
accordance with the study done by Shabina Ariff et al (2011) at Karachi,  
Pakistan, 123 there the incidence was in a range from 1.4% to 5.9%. This is also 
comparable with studies from developed countries. An Australasian study by 
Howell A et al (2009)  reported the incidence of 1.6% to 5%.50 Paolo Manzoni et 
al (2006) reported 8.1% of neonatal fungal sepsis  in their study.94 Chapman RL, 
Roger GF (2003) had observed the incidence of 2.2% to 16.5% .19 Stoll BJ et al 
(2002) also reported the above range of incidence.131       
 Distribution of fungal sepsis cases in relation to place of birth was analyzed 
in this study and it was found 8 cases ( 62%) were among out born babies who  
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were delivered elsewhere and referred to the higher institutions  for further 
management. These cases were usually admitted in Sick Newborn Nursery 
(SNN).This was reported in same manner by Shabina Ariff et al (2011), in their 
study there was 64% of fungal sepsis cases of out born. 123  According to the report 
of  National Neonatal Perinatal Database and Sankar et al(2008) sepsis is 12 times 
common among out born babies admitted in tertiary care hospital.118 In 
developing countries most of the deliveries are conducted at primary and 
secondary care hospitals, private hospitals and at home with the help of traditional 
birth attendants and most of them are referred to tertiary care hospital. This may be 
probable reason for exposure to environmental pathogens which   leads to higher 
incidence of neonatal sepsis with invasive fungal agents.      
  In this study, the fungal sepsis was distributed more or less equally 
among both sexes and there was 7 cases(54%) in male neonates and 6 cases(46%) 
in female neonates.. This is in accordance with the study done by Daynia E. Ballot 
et al (2013) at South Africa, there was also male preponderance (57%).27 This is 
also similar to another study done by Paolo Manzoni et al (2006) who reported 
male preponderance (54.5%).94 The gene located at X chromosome  involves with 
the function of thymus or with the synthesis of immunoglobulin and presence of  
double X chromosome in female gender leads a greater resistance to infection. This 
 130  
was explained by Bellani AJ, Schlegel (1969), in the textbook of Infectious 
Disease of the Fetus and Newborn.14     
 Birth weight is one of the important criteria for selection of cases. In this 
study 3 cases (23%) of fungal sepsis were of normal birth weight  but 10 cases 
(77%) were LBW neonates. The incidence is more than threefold in LBW 
neonates. Among this 10 cases, 6 (60%) cases are in VLBW and ELBW babies. 
This is similar to the  study done by Carey AJ et al (2008), they reported a range 
of 44% to 75% of fungal sepsis among VLBW and ELBW babies.18 In US, 
Neonatal Research Network Study (2008) observed a cumulative increase of 
incidence from 2.4% to 20.4% between normal and LBW neonates. Birth weight of 
a newborn is not only depending upon the gestational age at birth, but it also 
depends on maternal factors like antenatal care, nutrition, maternal infection or 
illness, multiple gestations, twin pregnancy, uterus and placental anomalies and 
fetal factors like  congenital infection or anomalies and inborn error of metabolism.      
  Gestational age at birth decides the maturity of the newborn and 
indicate the  immune status of each individual at birth.  Gestational age at birth is 
inversely related to occurrence of neonatal sepsis. In this  study,  9cases (69%) of 
fungal sepsis are preterm ( below 37 weeks) and among them 5 cases are below 34 
weeks of gestation, one is below 30 weeks with ELBW. This finding  is in 
accordance with the study done by Fridkin SK et al (2006) at US, with clear 
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association in preterm birth with increasing incidence of fungal sepsis from10% to 
16% for decreasing gestational age at birth.37       
 Risk factor analysis done for all of the positive cases and their association 
with infection and sepsis were studied. Prolonged hospital stay implicated for 54% 
of cases. This is similar to Huang et al (1998) study, there was more than 50% of 
sepsis among prolonged stay at hospital.51 An Indian study by Singh K et al, 
(1999) reported 22.8%  of invasive fungal infection in preterm neonates staying 
more than 1 week in NICU.123 This is mainly due to cross infection in the hospital 
environment but it can be prevented by strict adherence to infection control 
practices  and proper instructions to the health care workers in NICU to follow the 
universal precautions.         
 Mechanical ventilation is one of the life saving measure in severe birth 
asphyxia, preterm neonates with severe  respiratory distress syndrome (RDS), 
meconium aspiration syndrome with respiratory failure, severe sepsis with multi 
organ dysfunction, metabolic acidosis and some cases of neonates under post 
poerative care. Such a important intervention may increase the chances of 
invasivse infection and sepsis. In this study there are 6 cases (46%) of fungal sepsis 
put on to mechanical ventilatiory care for various indications. This is in accordance 
with a  study done in Taiwan by Bai-Horang Su, Hsin- Yang Hsieh et al (2006), 
and it was reported increasing incidence up to 20% in mechaical ventilation care.10 
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 Umbilical line device is used as a port for giving infusions, drugs and 
transfusion. Umbilical catheterization should not routinely be done for all neonates 
and it is useful in some therapeutic interventions like exchange blood transfusion 
and at the time of difficulty in getting peripheral venous line. In this study, only 13 
cases were on  umbilical line  and all of them were only for exchange blood 
transfusion, of these only one case (7.6%) was affected by fungal sepsis.. 
Prolonged duration of umbilical line may lead to more number of infections as 
stated by Daniel K Benjamin et al (2010) in their observation and a rise of 
incidence up to 28% was reported.25      
 Surfactant deficiency is commonly encountered in preterm babies born 
before 30 weeks of gestation. Surfactant therapy is given to such neonates in all 
tertiary care NICUs. It is administrated directly into lungs trough endotracheal tube 
and put on to mechanical ventilation for few hours to few days. In this study, 
surfactant therapy is noted as a risk factor in one case (7.6%) of fungal sepsis. 
Paolo Manzoni et al (2006) reported the association was 78% for progression to 
invasive fungal infection.94 In developing countries, Surfactant therapy is given 
only in well established NICU and the number of such therapy are less in 
comparison with developed countries.      
 Association of broad spectrum antibiotics administration above 5 days was 
64%amoung the fungal sepsis cases. This is in accordance with a study conducted 
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by   Rodrignez D et al (2006)  and  there  was more than  50%  association with 
broad spectrum antibiotic usage.110 Broad spectrum antibiotics usage may lead to 
suppression of normal bacterial flora of oral and gastrointestinal mucosa, it allows 
the overgrowth of fungal pathogen like Candida species, which progress to 
invasive infection. Prolonged antibiotic therapy needs a central or peripheral 
venous line, if it kept for prolong period it may increase the chances of  
colonization and invasion by fungal pathogens. So frequent changing of venous 
line will reduce the risk.      
  Most of the cases of fungal sepsis occurred as late onset sepsis .In this study 
about 75% of cases were in this category. This is similar to the study done by 
Tushar B,Parikh et al (2006) in India that the percentage of fungal infection 
detected beyond 7 days was 60% and beyond 3’rd  & 4'th   week was 20%.134 In 
EOS, the fungal sepsis is less common and it is mostly transmitted through birth 
canal of the mother during delivery. The nosocomial environment is associated 
with more LOS cases in NICU. This is modified by well designed NICU with 
improved care and proper screening of suspected neonates.     
  There are several markers used for screening of a suspected neonatal 
sepsis. Among them thrombocytopenia is important indicater in fungal sepsis. 
CRP is elevated in most of the acute illnesses and infections. I/T ratio is also one 
of the valuable marker of sepsis. In this study, septic screening reports were 
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analyzed and compared for all fungal sepsis cases. There was 100% positivity of 
CRP (>1.0mg/dl), elevated I/T ratio >0.2 in all cases .Thrombocytopenia was 
noticed in 10 cases (76%) and decreased total count noted in 9 cases (69%).This is 
in accordance to the reference value charts formulated by Monroe BL, et al 
(1979) and Mouzinho A, et al (1994), which concludes  that if there were two 
abnormal parameters in a screening,  is 93-100% sensitivity  and 83% 
specificity.87,90 It was also updated  by David Kaufman (2014), the association of 
thrombocytopenia with neonatal Candida infection.26     
  All of the thirteen fungal pathogens were Candida species. This is in 
accordance with David A Kaufman (2014) and Hasen Tezer et al(2012). They 
reported Candida species was the leading fungal pathogen for neonatal fungal 
sepsis.26,48           
   Aspergillus species infection is common among preterm neonates. It is 
transmitted by air born fungal spores. Infection is usually due to contaminated 
dust exposure. This study is conducted in a well established NICU at tertiary care 
centre. A clean dust free environment is maintained at all time inside the NICU. 
Transmission through skin is rarely encountered but it needs a primary focus for 
spread. So, no such fungi was isolated from the samples.      
 Malassezia furfur is a lipophilic fungus, which usually needed a media with 
lipid content like lipid infusion prepared for total parentral nutrition (TPN). TPN 
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is infused to most of the VLBW, ELBW, necrotizing enterocolitis(NEC) and post 
operative neonates. Because of the  higher cost of such treatment, such therapy 
was not administered in the study centre, and so it was not reported.   
    
  Zygomycetes is another emerging fungal pathogen isolated in few cases of 
neonatal sepsis. The mode of transmission is trough skin with local trauma and 
intravenous line contamination. But these fungal patogens are found only in the 
polluted environment. In a well maintained NICU, the infection by this pathogen 
is less likely encountered.                    
  Species level distribution of the Candida is analyzed in this study. There is 
equal distribution C. albicans(23%) and C.gullermondii (23%)among the isolates. 
The C. glabrata(15%) is next to these and one isolate of C. tropicalis, C. 
parapsilosis,C. dubliniensis, C.krusei and C. kefyr(7.6% )each. K. Sesu kumari et 
al(2014) isolated predominant non albican Candida species (65%) from various 
clinical samples in their South Indian study.61  Fridkin et al (2006) reported a 
similar pattern of distribution with C. glabrata  C parapsilosis, C. tropicalis and C. 
krusei in their study.37 Ali Zarei et al (2013) isolated  48% of non albican 
Candida species like C. glabrata,  C. tropicalis and C. krusei in candiduria study. 
In last decade, several reports stated that non albicans Candida is an emerging 
pathogen.3 Selma Amaral Lopes and Andressa Moura (2012) reported three 
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cases of C,Krusei in their neonatal fungal sepsis study at Brazil.122   
  V P Baradkar et al(2008) also reported a case of C. dubliniensis. The less 
common species like C.gullermondii and C.kefyr were also isolated in this 
study.135 The  C.gullermondii was isolated in NICU by K. Sesu kumari et 
al(2014)) in their study.61 It is considered as environmental pathogen and 
transmitted through heparin solution used to flush the needles. C.kefyr was 
previously designated as C. pseudotropicalis rarely involved in human infections. 
   Antifungal susceptibility pattern is analyzed in this study. There  
resistance pattern noted was as follows- Flucanazole (30%), Amphotericin 
B(23%) and Itraconazole(17%). Upto 15% resistances for Nystatin. All isolates 
were susceptible to Voriconazole . Azole drugs are not tested against C. krusei 
because of its  intrinsic resistance. Some strains of C. krusei also have intrinsic 
resistances for Amphotericin  B. All isolates of  C. albicans, C. glabrata  and   
C.tropicalis were resistant to more than one drug. Many stains of C. glabrata are 
susceptible dose dependant or intrinsically resistant to Azole drugs.     
  Acquired drug resistances to Azole drugs is increasingly noted in  most of C. 
albicans isolates. Yang YI et al (2003) study is comparable with this study, which   
reported 20% to 33% of drug resistance to Azole drugs. There was 12% resistance 
for Amphotericin B and  48% resistance to Flucanazole among C.albicans. C. 
glabrata showed 4% resistance, 60% susceptible dose dependance for  
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Amphotericin B and 28% resistance, 64% susceptible dose dependance for 
Flucanazole. 146            
Nystatin is used orally to reduce gut colonisation. Amphotericin B and 
Flucanazole are preferred for treatment in most of the neonatal fungal sepsis. 
Because of the toxicity of Amphotericin B deoxycholate and high cost of 
liposomal preparation, fluconazole is used in many centers.    
   Fluconazole prophylaxis is suggested for preterm < 30 weeks of 
gestational age, VLBW,ELBW and acute onset thrombocytopenia neonates by 
Tushar  B,Parikh et al(2006).114 The usual regimen is 6mg/ kg for every 3rd day 
in the first week of life and then every 2nd day from second week up to 30 days 
for VLBW and 45 days for ELBW neonates.      
  Biochemical reactions like sugar fermentation and sugar assimilation are 
useful for further speciation of Candida.  CHROMEagar and kit based sugar 
assimilation are rapid methods for identification of candida species but the cost of 
each test  limits their routine use. Antifungal susceptibility testing must be done 
for all isolates to give proper guidelines for treatment and to control the 
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SUMMARY 
 The study on Characterization and speciation of fungal isolates in neonatal 
sepsis in a tertiary care hospital revealed a incidence of 6.5% fungal sepsis. The 
important risk factors noted were male preponderance (54%), prematurity (69%), 
and low birth weight (77%). Most of the sepsis cases were presented as late onset 
sepsis (75%). Modifiable risk factors like administration of broad spectrum 
antibiotics (62%), prolonged hospital stay (54%) and mechanical ventilation care 
(46%) have played an important causative role for colonization and infection. 
Blood transfusion, surfactant therapy and umbilical catheterization also were 
associated risk factors of fungal sepsis.  Thrombocytopenia was one of the 
important marker for fungal sepsis along with increased I/T ratio, raised CRP and 
reduced total WBC count. Only Candida species were isolated from the culture 
positive specimens. Among them C.albicans(23%) and C.gullermondii(23%) were 
the common pathogens. Antifungal susceptibility pattern showed 100% 
susceptibility to Voriconazole and 30% resistance for Fluconazole and 23% to 
Amphotericin B.          
 Presumptive identification of fungal isolates was done by wet mount, Gram 
staining, India ink and it was confirmed by conventional fungal culture method. 
Further processing of growth with microscopic methods like germ tube test and 
corn meal agar were done for the speciation of the organism. Sugar fermentation 
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and sugar assimilation tests were performed for the confirmation of osolates. Rapid 
kit based identification test and CHROMEagar growth were the additional tests 
that improved the outcome. Antifungal susceptibility pattern of the isolates were 
tested by disc diffusion, agar dilution methods and the MIC of the fungal isolates 
were determined by macro broth dilution and micro broth dilution technique, micro 
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CONCLUSION 
The study on Characterization and speciation of fungal isolates in neonatal sepsis 
in a tertiary care hospital revealed the following findings:    
 1)     Among the 200 selected cases of neonates ,fungal pathogens were 
isolated from 13 cases and the incidence of fungal sepsis was 6.5%  
 2)Maximum cases were among out born neonates(62%) those who delivered 
at varies centers like PHC, Government HQ hospitals, Private hospitals and even at 
home. There were more chances for exposure to pathogens in outside delivery, 
while handling and transportation to the tertiary care hospital.    
 3)Among  the fungal sepsis cases, 54%  were  male  neonates as female 
babies have a better resistance to infection by possessing double X chromosome 
which are the dominant factor in immune development.           
 4) Prematurity (69%) and low birth weight (77%) were major risk factors for 
fungal sepsis. Immature immune system  among them was the main factor of 
concern.           
 5) Among the risk factors, administration of broad spectrum antibiotics 
(62%), prolonged hospital stay for more than 7 days (54%)  and transfusion 
(54%) had major contributions. Intervention like mechanical ventilator care (46%), 
umbilical catheter insertion (7.6%) and surfactant therapy (7.6%) were also 
implicated as important risk factors. The causative role of the above factors is 
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modifiable one by creating awareness and giving better training for all health care 
workers.             
 6) Thrombocytopenia (platelet count <1,00,000  cells/ cmm), elevated  I/T 
ratio > 0.2  and  raised CRP were the relevant septic screen markers. Presence of 
these markers in neonates with suspected sepsis will gives  clue to rule out  fungal 
sepsis.           
 7) Conventional culture methods by itself is adequate to identify and 
speciate the fungal pathogen.         
  8) Candida species were the only pathogen isolated from samples. 
C.albicans (3),   C. guillermandi (3) & C.glabrata (2), each one of C.tropicalis , 
 C.parapsilosis, C.kefyr, C.krusei, C.dubliniensis were  isolated from the 
clinical samples.          
 9)   Resistant pattern observed for Fluconazole (30%),  Amphotericin B 
(23%), followed  by Itraconazole (17%), Nystatin (15%). All isolates were 
susceptible to Voriconazole. Voriconazole is used as the second line drug for most 
of the resistant fungi now a days. Antifungal susceptibility testing and MIC 
determination by microbroth dilution method will guide in selecting appropriate 
antifungal agents and to reduce the emergence of resistance.   
 10) Proper care for preterm neonates, restricted usage of broad spectrum 
antibiotics, early removal or replacement of indwelling catheters or devices, 
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reducing the unnecessary intervention, early initiation of enteral feeding  and 
earlier discharge will help in controlling the nosocomial spread of fungal pathogen.  
 11)  Prevention of fungal sepsis starts from antenatal period. Proper 
screening for genital infection and treatment during ANC period is the first step.  
Standard precaution should be followed in every hospital for a clean delivery. 
Transit of sick neonates with all precaution will help to avoid exposure to 
pathogens. Avoidance of unwanted admissions, early discharge of healthy neonates 
and following  universal precaution will reduce the disease burden.    
  12) As neonatal sepsis is one of the major cause for neonatal mortality and 
morbidity, evaluation of suspected cases for bacterial and fungal pathogens are 
immense important. Similar studies about screening and surveillance of fungal 
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Annexure -i 
    REAGENTS      
 1.Gram staining reagents;        
  1.Primary dye - Methyl Violet - 0.5%      
  2.Gram's iodine solution        
  3. Decolorizer - Acetone.        
  4. counter stain - dilute carbol fuchsin (1:10)     
  Gram's iodine prepared by dissolving 2 g of potassium iodide in 25 ml 
of water, then adding 1 g of iodine crystal and make up to 100 ml with distilled 
water.             
         
 2.LACTOPHENOL COTTON BLUE STAIN (LPCB) 
 Useful as a fluid mount for microscopic observation of fungi. 
Phenol     20 gm [ Melt in warm water then weigh ] 
Lactic acid     20 gm 
Glycerol     40 gm 
Cotton blue     0.05 gm 
D. W.      20 ml 
Add - lactic acid, Glycerol, Phenol and DW 
Then dissolve with even heat 
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Annexure -ii   
     MEDIA 
1. SABOURAUD DEXTROSE AGAR (SDA) 
   Emmons modification  
Dextrose    20 gm 
Neopeptone    18 gm 
Agar     20 gm 
Distilled water   1000 ml 
Final pH    6.8 - 7 
Dissolve the ingredients by boiling, dispense in tubes and autoclave at 121℃ for 
15 mins. 
Allow the tubes to cool in slanted position. 
Store in refrigerator at 4℃. 
Shelf life of 30 days in test tubes and 14 days in petri dishes. 
SDA with gentamicin and chloramphenicol 
Gentamicin     0.5 mg/ml 
Chloramphenicol    0.05 mg/ml 
Add 50 mg of  Gentamicin in 10 ml of acetone and 50 mg of Chloranphenicol in 
10ml 95% alcohol and add these to the boiling Sabouraud medium. 
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Mix the medium thoroughly. Tube and autoclave at 121℃ 10 min.   
2. POTATO DEXTROSE AGAR (PDA) 
(Peel, slice, and boil potatoes in 100 ml of distilled water for 1 hour filter and add 
the following) 
Dextrose     20.0 gm 
Agar      20.0 gm 
Distilled water    To make final volume to 1 lt. 
Bring to boil to dissolve agar. 
Autoclave at 121℃ for 15 minutes.        
3.CORNMEAL AGAR (CMA) 
Cornmeal Agar with Tween 80 
Yellow cornmeal    40 gm 
Distilled water    1000 ml 
Agar      20 g 
Heat Cornmeal in a water bath in 60℃ for 1hr. 
Filter through gauze. 
Bring the level of filtrate to 1000 ml. 
Add 2% Agar. 
Autoclave at 121℃ for 15 minutes. 
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To plain cornmeal Agar add Tween 80(10  ml) 
 and pour in sterile petri dishes. 
Shelf  life is 14days. 
3.Christensen's urea agar       
 Glucose                                           5 g      
 Sodium chloride                          5 g      
 Potassium dihydrogen phosphate   2 g          
 Peptone         1 g      
 Agar          20 g      
 Water          1 lit      
4. Brain Heart Infusion (BHI) broth       
 This is reconstituted from dehydrated form ( brought from Hi Media Lab, 
Mumbai) according to manufacturer's instructions.      
 Miniature bottles (15 ml) were used and 5 ml of BHI broth was filled in each 
bottles            
 Autoclaved with caps tight at 121℃  for 15 mts.     
 Used in neonates where the small volume of  blood collection (0.5-1ml) was 
advised.                
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5. CARBOHYDRATE FERMENTATION MEDIA FOR YEASTS ( sugars 
used are dextrose, maltose, sucrose, lactose, galactose, trehalose & cellobiose) 
Sugar       1.0 gm 
Nutrient broth     100 ml 
Bromothymol blue ( 0.2% alcoholic )  1.2 ml 
distribute as 5 ml per tube and introduce Durham's tube inside all broth, autoclave 
at 115℃ for 10 minutes. 
6. CARBOHYDRATE MEDIA FOR ASSIMILATION OF YEASTS 
a) Yeast nitrogen base agar 
Yeast nitrogen base    0.67 gm 
Agar                20 gm 
Distilled water     1000 ml 
autoclave at 115℃ for 15 minutes prior to use. 
Carbohydrate solution (20%) (sugars used are dextrose, maltose, sucrose, lactose, 
galactose, melibiose, trehalose, cellobiose, inositol, xylose, raffinose, & dulcitol) 
Sugar     20 gm 
Distilled water   100 ml 
Autoclave at 115℃ for 10 minutes and store as stock solution. 
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7. Mueller- Hinton agar (with+ 2% dextrose and 0.5 µg of methylene blue 
dye/ml) 
 Beef infusion         300 ml       
 Casein hydrolysate  17.5 g       
 Starch   1.5 g        
 Agar    10 g        
 Distilled water  1 lit        
 Dissolve the constituents by gentle heating at 100℃ with agitation  
 Sterilize by autoclaving at121℃ for 15 mts.      
 Add sterile methylene blue dye 0.5 µg/ml and pour in sterile petri dishes 
             
8. Micro broth Dilution antifungal susceptibility Testing 
Specimen Requirements  
Yeast  
All yeast isolates must be streaked for isolation onto Potato Dextrose agar (PDA). 
Bacterial contamination interferes with testing. 
Subculture yeast to PDA agar quadrants and incubate at 30°c for 24-72 hours prior 
to testing.  
Reagents            
Antifungal Drugs  
 174  
RPMI-1640  
Sterile Distilled Water  
Dimethyl sulfoxide (DMSO ) 
Sabourarud Dextrose Agar  
Equipments  




Adjustable pipette in 1-1000 ranges. 
Supplies  
0.22 nm filter system 
10 ml pipette 
5 ml pipette 
15 ml centrifuge tubes 
12*75 snap cap tubes 
Sterile wooden applicator sticks 
96-well round bottom microtiter 
Pipette tips 
Sterile transfer pipettes 
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Media Preparation 
 Broth medium was RPMI 1640 broth buffered with MOPS buffer (0.165 M) and 
0.2% dextrose and glutamine without sodium bicorbanate to a pH of 7.0.  Media 
was brought from HiMedia laboratories Pvt. Limited, Mumbai   
Concentration tested 
Concentrations should reflect the breakpoint concentrations and/or the expected 





Drug stock preparation 
Amphotericin B 
Pharmaceutical grade powder-refrigerated 
Using calculation, determine amount of powder to weigh for 10ml in 1600 µg/ml 
stock. 
Dilute powder in 10 ml DMSO (100%) 
Store 2.0 ml 1600 µg/ml aliquots at -70°c for one year  
Makes 5 stocks ready for drug set preparation 
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Drug dilution sets are prepared in 100% DMSO with a final volume of 1ml of each 
concentration and stored at -70°c for one year 
Remove sets as necessary to prepare plates. 
Fluconazole:  Pharmaceutical grade powder-room temperature 
Using calculation, determine amount of powder to weigh for 10 ml of 6400µ g/ml 
Dissolve powder in 10 ml DMSO 100% 
Freeze 2 ml of 6400 µg/ml aliquots at -70°c for one year 
Remove sets as necessary to prepare  
Plate preparation  
Remove drug set from freezer and allow to thaw 
Label plates with drug initials on top side panel and concentrations under Wells 
along the bottom top panel 
Determine the amount of RPMI required. To prepare plates by multiplying the 
desired number of plates by 0.8. This will provide the minimum amount of media 
required to make plates. Add one additional MLS to this amount to account for 
pipetting errors, etc. 
Label media tubes with desired end concentration for tubes 1- 10. Mark tubes 11-
12 with C for control. 
Dispense the desired volume of RPMI in to each tube 
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Add the corresponding drug/diluent (for controls) to each labeled tube In a 1:50 
ratio. To determine the amount to add, use the followig equation (RPMI volume in 
this sample is 10 ml): 
1/49 = x/10 
49x=10 
X=0.204 
Add 204 l DMSO to each of the 2 Control tubes  
Add 204 l of each drug dilution to each labeled tube containing 10 ml of RPMI 
Dispense 200µ l DMSO Control in column 12 and 100µl in column 11 
Dispense 100µ l drug to appropriate columns using a multi-channel pipette 
Inoculum preparation yeast 
Yeast 0.5-2.5 * 10 ⁵ 
Subculture yeast isolates on PDA for 24-72 hours prior to setup and incubate at 
30°c  
Remove 24-72 hour subcultures from 30°c incubator. 
Label 12 * 75 snap cap tube with FTL# and add approximately 3.0 ml sterile 
distilled water to the tube 
Place tube within the spectrophotometer/densicheck and adjust to 0 OD 
Using a sterile wooden applicator stick add a small amount of appropriate yeast 
isolate to the tube 
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Measure the OD and adjust to target of 90%T (Spectrophotometer) or 0.45-0.55 
OD densicheck 
If %T/OD is 92 or higher/0.44 or lower, add more yeast. If 88/0.55 or higher, Add 
more water. Continue until target %T/Odd is reached. 
Place yeast suspension in refrigerator or ice chest until ready for use. 
Yeast suspensions should be used within 2 hours of preparation. 
Inoculating Plates 
Yeast 
Add 10µl to each 5 ml of media 
Vortex and pour media into sterile Petrified dish 
Add 100 µl of inoculum to each well (1-11) in appropriate row  
Incubation  
Place plates in a plastic bin with a water reservoir 
Place bin in 35°c incubator  
For isolates that do not grow at 35°c within 72 hours, place plates at room 
temperature until growth is detected. 
Reading results yeast 
Time of reading  for Amphotericin B, 24 or 48 hours and for fluconazole 48 hours.  
MIC by visual examination measured for Amphotericin  B as lowest drug 
concentration that prevents any discernible growth (100% inhibition).  
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 MIC by visual examination measured for Fluconazole as lowest drug 
concentration that shows prominent (~50%) decrease in turbidity. 
9. Macro broth dilution method 
 This was done in test tubes instead of  microtiter wells used in micro broth 
dilution method.           
 Test inoculum preparation with a dilution of  1:2000made from stock 
inoculum suspension; inoculum size after inoculum, 0.5✗ 10³ to 2.5✗ 10³ CFU/ml.
 Drug dilution was done by adding drug with additive ( DMSO) 10 ✗  
dilutions for Fluconazole and drug with solvent (DMSO) 100 ✗ dilution for 
Amphotericin B.          
 Drug and inoculum mixing done by adding 0.1 ml of drug and 0.9 ml of 
inoculam to small sterile test tubes. 10 tubes for different drug range ,11th tube for 
inoculam control and 12th one for media control .      
             
        
             
             
    
 
 













 NI - NICU, S - SNN, PS - Pediatric Surgery,  
  
 I - Inborn, O - Out born,  
  
 M - Male, F - Female,  
  
 T - Term, P - Preterm,  
  
 NW - Normal birth weight,  L - LBW,  V - VLBW, E - ELBW,   
  
 Y -Yes, N - No,  
  
 B - Blood, CSF - Cerebro Spinal Fluid,  U - Urine,  
  
 G - Growth, NG - No Growth.   
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1 Serial No 1 2 3 4 5 6 7 8 9 10 
2 Lab ID No 1025 1059 1055 1121 1134 1136 1122 1127 1153 1154 
3 Ward (NICU/SNN/PSU) NI NI NI NI S NI NI S S S 
4 Place of Birth(Inborn/Out born) I I I I O I I O O O 
5 Age in days 8 7 8 3 6 5 5 25 6 10 
6 Sex(Male/Female) M F M F F M F M M F 
7 Maturity (preterm/term/post term) PT PT PT PT T PT PT T PT PT 
8 Birth Weight(N/LBW/VLBW/ELBW) L L L L L L V NW L L 
9 Use of surfactant(Yes/No) N N N N N N N N N N 
10 Use of umbilical line(Yes/No) N N N N N N N N N N 
11  Administration of broad  spectrum antibiotics/Duration Y/5 Y/6 Y/7 Y/3 Y/6 Y/5 Y/5 Y/7 Y/6 Y/5 
12 H/O Transfusion(blood/blood  products/exchange) N N N N N N Y N N N 
13 Duration of hospital stay  8 7 8 3 5 5 5 8 6 5 
14 Mechanical ventilator care (yes/No)/Duration N N N Y/3 N N Y/3 N N N 
15 H/O Major surgery(Yes/No) N N N N N N N N N N 
16 Total cell count(cells/cmm) 6000 7500 9000 5500 14000 9500 14000 3400 12800 13000 
17 Immature to total neutrophil ratio(I/T ratio) 0.2 0.2 0.24 0.34 0.2 0.3 0.36 0.25 0.32 0.24 
18 Platelet count(Cells/cmm) 1.5l 2.4l 1.4l 66000 - 1.2l 34000 68000 2.3l 2.5l 
19 CRP(+ve/-ve) - - - + + + + + + + 
20 Proven bacterial sepsis by culture(Yes/No) N N N N N Y N Y Y Y 
21 Nature of specimen processed(Blood/CSF/Urine) B B B B B B B B B B 
22 Fungal culture report(growth/no growth) NG NG NG NG NG NG NG NG NG NG 
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1 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 
2 1155 1166 1182 16704 1193 1202 1225 1226 1231 1273 1250 1254 1255 1257 17620 17622 1268 
3 S NI S S NI NI S S S S S S S S S S NI 
4 O I O O I I O O O O O O O O O O I 
5 7 8 10 5 7 11 5 12 7 3 5 13 7 3 5 6 12 
6 M M F M M F M M M F F F F M M M M 
7 T T P T T P PT P P P P T P PT P T T 
8 L L L NW NW L L V NW V L L V V L L L 
9 N N N N N N N N N N N N N Y N N N 
10 N N N N N N N Y N N N N N N N N N 
11 Y/7 Y/7 Y/5 Y/3 Y/5 Y/7 Y/5 Y/5 Y/3 Y/3 Y/5 Y/7 Y/5 Y/3 Y/5 Y/5 Y/7 
12 7 8 5 5 7 11 5 5 5 3 5 7 7 3 5 5 12 
13 Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y 
14 N N N Y/3 N N N N N N N N Y/3 N Y/3 N N 
15 N N N N N N N N N N N N N N N N N 
16 6700 16000 12500 2800 4400 7200 8800 4200 12000 4400 9200 - 6800 - 8600 4200 12000 
17 0.2 0.22 0.28 0.36 0.2 0.2 0.27 0.30 0.3 0.2 0.2 - 0.4 - 0.3 0.2 0.26 
18 1.5L 68000 1.2L 60000 1.6L 3.2L 1.8L 1.1L 1.2L 98000 1.4L - 44000 - 78000 68000 4.1L 
19 - + + + - - + + + + - - + - + + + 
20 N Y Y Y N N Y Y Y Y N N N N N N N 
21 B B B CSF B B B B B B B B B B CSF CSF B 
22 NG NG NG G NG NG NG NG NG NG NG NG G NG NG NG NG 
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1 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 
2 1268 1272 1300 1304 1315 1319 1320 1331 1332 1352 1354 1355 1364 1380 1382 1383 1402 
3 S S S S S NI NI NI S NI S S NI NI S NI NI 
4 O O O O O I O I O I O O I I O I I 
5 7 8 7 19 5 15 5 8 5 8 21 6 8 3 8 7 5 
6 F F M F M F M F F M M F F M F F F 
7 T T T T PT T PT T PT T T PT T PT T PT PT 
8 NW L NW NW L NW V L L NW L L NW V L L L 
9 N N N N N N Y N N N N N N N N N N 
10 N N N N N N N N N N N N N N N N N 
11 Y/5 Y/4 Y/3 Y/7 Y/4 Y/7 Y/3 Y/7 Y/3 Y/7 Y/5 Y/5 Y/8 Y/3 Y/3 Y/7 Y/5 
12 5 4 3 8 4 15 5 8 3 8 8 6 8 3 3 N N 
13 Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y 
14 N N N Y/3 N N Y/2 N N N N N N N Y/3 N N 
15 N N N N N N N N N N N N N N N N N 
16 - 14000 8800 6200 6500 8400 4400 11000 12200 14000 - 12000 10000 - 12000 9800 14400 
17 - 0.3 0.23 0.24 0.2 0.25 0.3 0.32 0.2 0.33 - 0.27 0.4 - 0.2 0.4 0.34 
18 - 1.6L 2.8L 2.2L 1.6L 1.8L 78000 2.6L 1.4L 2.2 - 2.6 90000 - 1.6L 1.2L 3.2L 
19 - + + + - + + + + - - + + - + P P 
20 N Y Y Y N Y Y Y Y N N Y Y N Y Y Y 
21 B B B B B B B B B B B B B B B B B 
22 NG NG NG NG NG NG NG NG NG NG NG NG G NG NG NG NG 
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1 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 
2 1403 1404 1405 1444 1447 1480 1481 1511 1512 1513 1517 1518 1520 1524 1536 1537 1538 
3 NI NI S S NI NI NI NI NI NI NI S NI S S S NI 
4 I I O O I I I I I I I O I O O O I 
5 20 16 8 9 7 4 7 7 7 5 11 15 7 3 8 14 6 
6 M M M M M M M M M F M M F M M F F 
7 T T T T T PT T T PT T T PT T PT PT T PT 
8 NW NW L L L V L NW L L NW L L V L L L 
9 N N N N N N N N N N N N N N N N N 
10 N N N N N N N N N N N N N N N N N 
11 Y/7 Y/7 Y/5 Y/7 Y/5 Y/3 Y/5 Y/5 Y/3 Y/3 Y/5 Y/7 Y/5 Y/3 Y/5 Y/5 Y/6 
12 N N N Y N N N N N Y N N N Y Y N N 
13 20 16 5 8 7 4 7 7 7 5 11 10 7 3 Y 5 6 
14 N N N Y/3 N Y/3 N N N N N N N N Y/3 N N 
15 N N N N N N N N N N N N N N N N N 
16 8800 9600 12500 4000 16000 8800 16000 18000 19000 1400 7000  20000 4800 4600 14000 12000 
17 0.32 0.22 0.2 0.3 0.25 0.2 0.2 0.33 0.3 0.24 0.25 - 0.4 0.38 0.3 0.32 0.26 
18 2.4L 1.6L 1.2L 38000 2.6L 3.2L 1.8L 1.1L 1.2L 1.9L 1.4L - 1.4L 96000 68000 1.8L 2.1L 
19 + + + + + - + + + + + - + - + - + 
20 Y Y Y Y Y N Y Y Y Y Y N Y N N N Y 
21 B B B B B B B B B B B B B B B B B 
22 NG NG NG G NG NG NG NG NG NG NG NG NG NG G NG NG 
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1 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 
2 1548 1549 1578 1579 1582 1596 1636 1637 1646 1648 1650 1652 1665 1666 1667 
3 NI S NI NI S NI S S PS S NI NI PS NI NI 
4 I O I I I I O 0 I O I I O I I 
5 7 7 8 8 32 7 4 4 7 8 8 8 4 7 5 
6 F M F F F F M M M F M M M F M 
7 T PT T T T T P P T P P T T P P 
8 L V L L NW L V E NW L L NW NW L L 
9 N N N N N N Y Y N N N N N N N 
10 N N N N N N N N N N N N N N N 
11 Y/5 Y/7 Y/3 Y/3 Y/7 Y/7 Y/4 Y/4 Y/7 Y/3 Y/7 Y/7 Y/4 Y/7 Y/4 
12 N N N N N N Y Y Y Y N N N N N 
13 7 7 8 8 11 7 4 4 7 3 8 8 4 7 5 
14 N N N N Y/3 N Y/1 Y/3 N N N N N N N 
15 N N N N N N N N Y N N N Y N N 
16 12300 4600 22000 8100 7600 12000 18000 5600 18000 18600 8400 13000 12000 14800 8500 
17 0.2 0.4 0.3 0.2 0.4 O.23 0.2 0.36 0.36 0.2 0.3 0.2 0.4 0.3 0.2 
18 2.2L 60000 87000 1.1L 2.0L 1.4L 1.4L 44000 1.2L 62000 1.4L 2.1L 72000 2.6L 1.4L 
19 + - + + + + - + - + - + + + + 
20 Y N Y Y Y Y N Y N Y N Y N Y Y 
21 B B B B B B B B B B B B B B B 
22 NG NG NG NG NG NG NG NG NG NG NG NG NG NG NG 
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1 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 
2 1669 1671 1672 1691 1693 1694 1696 1713 1726 1727 1728 1729 1744 1747 1748 
3 S NI NI NI S NI NI NI S NI NI NI NI S PS 
4 O I I I O I I I O I I I I O I 
5 8 5 10 8 5 8 5 5 11 6 5 4 7 6 10 
6 F F M F M F M M F F F F F F M 
7 P T P T P T T P P P P P T P T 
8 L NW V NW V L L L L V L V V L L 
9 N N Y N N N N N N N N Y N N N 
10 N N N N N Y N N N N N Y N N N 
11 Y/3 Y/4 Y/9 Y/4 Y/4 Y/8 Y/4 Y/4 Y/7 Y/6 Y/5 Y/4 Y/7 Y/3 Y/5 
12 N Y Y Y N Y Y N N N N Y Y N Y 
13 3 5 10 8 4 8 5 5 8 6 6 4 7 6 8 
14 N Y/3 Y/4 N N N Y/4 Y/3 N Y/2 N Y/Y N N N 
15 N N N N N N N N N N N N N N Y 
16 13200 6800 4400 12300 14000 9000 5400 11000 23000 12000 6800 9700 21000 15000 16000 
17 0.23 0.2 0.3 0.2 0.2 0.23 0.3 0.2 0.2 0.22 0.24 0.3 0.4 0.2 0.25 
18 2.3L 67000 87000 1.2L 2.0L 1.1L 80000 2.2L 1.6L 2.2L 1.7L 96000 75000 1.9L 1.5L 
19 + + + - + + + + + - + - + + - 
20 Y Y Y N Y Y Y Y Y N Y N Y Y N 
21 B B U B B B B B B B B U B B B 
22 NG NG NG NG NG NG NG NG NG NG NG NG NG NG NG 
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1 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 
2 1749 1754 22712 3777 3467 1762 1763 1768 1777 1778 1779 1781 1803 1804 1808 1833 
3 S S S NI S S NI NI NI NI NI S S NI S S 
4 O O I I O O I I I I I I O I O O 
5 3 8 28 7 5 7 6 7 7 5 7 22 5 8 8 5 
6 F F F F M M F M M M M F F F M F 
7 P T P T T P P P T P P T P P T P 
8 E L L NW L E V L L V L L V V L E 
9 N N N N N Y N N N Y N N N N N Y 
10 Y N N N Y N N N Y N Y N N N N N 
11 Y/3 Y/5 Y/7 Y/7 Y/5 Y/7 Y/6 Y/7 Y/7 Y/5 Y/7 Y/5 Y/5 Y/8 Y/3 Y/5 
12 Y N Y N Y Y N N N N Y N N Y N Y 
13 3 5 10 7 5 7 6 7 7 5 7 8 5 8 3 5 
14 Y/3 N Y/3 N Y/4 Y/7 N N Y/2 N N N N N Y/3 Y/5 
15 N N N N N N N N N N N N N N N N 
16 19200 4500 14000 13000 20400 7200 9400 16000 7200 30000 10400 17000 24000 15300 5900 18000 
17 0.46 0.2 0.2 0.2 0.3 0.46 O.3 O.2 O.42 0.2 0.23 0.3 0.2 0.34 0.2 0.2 
18 1.2L 46000 1.6L 1.5L 1.2L 80000 94000 1.2L 66000 1.4L 1.4L 1.6L 90000 1.3L 78000 1.0L 
19 - + - - - + - + - - - + - + + - 
20 N N N N N Y N N N N N Y N Y Y N 
21 B B CSF CSF CSF B B B B B B B B U B B 
22 NG NG NG NG NG G G NG NG NG NG NG NG NG NG NG 
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1 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 
2 1830 1847 1857 1866 2624 1886 1890 1892 1893 1910 1930 1944 1946 1498 1902 
3 NI S NI NI S PS S S NI NI S NI S S NI 
4 I O I I I I O O I I I I O O I 
5 6 10 7 5 15 21 8 15 10 5 26 5 8 10 7 
6 M F M F F M F F M M M F M F M 
7 P T P T P P P T P P T P T T P 
8 V L L NW V L L NW L V NW V L L L 
9 Y N N N N N N N N Y N N N N N 
10 N N N N N N N N N N N N N N N 
11 Y/6 Y/4 Y/7 Y/5 Y/10 Y/7 Y/3 Y/5 N Y/5 Y/7 Y/5 Y/3 Y/5 Y/7 
12 N N N N N N N N N Y N Y N N N 
13 6 4 7 5 10 21 3 5 10 5 26 5 3 5 7 
14 Y/2 N N N Y/5 N N N N N N N Y/3 N N 
15 N N N N N Y N N N N N N N N N 
16 16000 7200 30000 10400 17000 14500 12300 4600 22000 8100 7600 12000 18000 10400 17000 
17 O.22 O.42 0.2 0.23 0.3 O.2 0.3 0.4 0.3 0.2 0.4 O.23 0.25 0.23 0.3 
18 1.2L 66000 1.4L 1.4L 1.6L 1.6L 2.2L 60000 87000 1.1L 2.0L 1.4L 1.4L 1.4L 1.6L 
19 + + - + + - + + + - + + + + + 
20 Y Y Y Y Y N Y Y N N N N Y Y Y 
21 B B B B CSF B B B B B B B B B U 
22 NG NG NG NG NG NG NG NG NG NG NG NG NG NG NG 
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1 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 
2 1967 1976 1980 3782 3698 1999 2000 2002 2028 2031 2032 2081 2110 2130 2134 
3 S S NI NI NI NI S NI S S S S S S S 
4 O O I I I I O I O O O I O I O 
5 18 27 9 17 16 5 8 18 12 8 7 7 7 10 20 
6 F M F F M M M M F F M F F F F 
7 T P P T P P P P T P P T P P P 
8 L V V NW L V L L NW V L NW V L L 
9 N N Y N N Y N N N N N N N N N 
10 N N N N N N N N N N N N N N N 
11 Y/7 Y/7 Y/5 Y/10 Y/6 Y/5 Y/3 Y/10 Y/7 Y/8 Y/3 Y/3 Y/7 Y/4 Y/7 
12 N N N N Y N N N Y N N N N N N 
13 8 8 9 17 16 5 3 18 8 8 3 7 7 4 8 
14 N N N N N Y/2 N N N Y/5 N N N N N 
15 N N N N N N N N N N N N N N N 
16 12300 14000 16000 17200 30000 14000 13000 20400 4600 7200 12000 13000 14000 7200 23000 
17 0.2 0.25 O.22 O.2 0.2 0.2 0.26 0.3 0.4 O.42 O.23 0.26 0.2 O.42 0.2 
18 1.2L 2.0L 1.2L 1.6L 1.4L 1.6L 1.5L 1.2L 60000 66000 1.4L 1.5L 2.0L 66000 1.6L 
19 + + + - - - - - + + + - + - + 
20 Y Y N N N N N N Y N N N Y N Y 
21 B B B CSF CSF B B B B B B B B B B 
22 NG NG NG NG NG NG NG NG NG G NG NG NG NG NG 
 190  
 
1 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 
2 2144 2145 2154 2170 2178 2200 2220 2225 2239 2266 2285 2289 2292 2294 2296 
3 S NI NI NI S S S PS S S S S S S NI 
4 O I I I O O O O O O O I O O I 
5 12 12 25 10 16 28 10 38 18 34 17 10 24 20 11 
6 F F M M F F M M M F M F F F M 
7 T P P P P P P T T P P P T P T 
8 L V L L V L V NW L L L V NW L NW 
9 N Y N N N N Y N N N N N N N N 
10 N N N N Y N N N N N N N N N N 
11 Y/5 Y/7 Y/10 Y/5 Y/7 Y/8 Y/9 Y/20 Y/8 Y/8 Y/3 Y/10 Y/7 Y/4 Y/7 
12 N N N N N N Y N N N N N N N N 
13 5 12 25 10 8 8 9 20 8 8 3 10 8 4 11 
14 N Y/2 N N Y/2 N Y/4 Y/5 N N N N Y/3 N N 
15 N N N N N N N Y N N N N N N N 
16 12300 14000 20400 4600 7200 23000 4400 16000 4600 12000 13000 20400 7600 6500 8400 
17 0.2 0.2 0.3 0.4 O.42 0.2 0.3 O.22 0.4 0.27 0.26 0.3 0.4 0.24 0.25 
18 1.2L 2.0L 1.2L 60000 46000 1.6L 1.7L 1.2L 60000 2.6 1.5L 1.2L 2.0L 1.6L 1.8L 
19 - P - P P P P P P P P P P P P 
20 N Y N Y N Y Y N Y Y Y Y Y Y Y 
21 B B B B B B U B B B B B B B B 
22 NG NG NG NG NG NG NG NG NG NG NG NG NG NG NG 
 191  
 
1 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 
2 2311 2326 2343 2362 2392 2407 2483 2498 2505 2522 2524 2545 2564 2579 2580 2581 
3 S S S NI S S NI PS S S NI NI NI NI NI NI 
4 O O I I O O I O O O I I I I I I 
5 22 28 18 28 16 6 5 34 12 5 5 8 5 8 8 9 
6 M F M F F M F F M F M F M F M F 
7 T T T PT T P P T P P P T T T P P 
8 NW L NW L NW L L NW L V L L NW L L V 
9 N N N N N N N N N Y N N N N N Y 
10 N N N N N N N N N N N N N N N N 
11 Y/8 Y/8 Y/3 Y/9 Y/5 Y/6 Y/5 Y/10 Y/6 Y/5 Y/3 Y/3 Y/5 Y/5 Y/3 Y/9 
12 N N N Y N N N N Y N N N N N N Y 
13 8 8 3 28 5 6 5 10 6 5 5 8 5 8 8 9 
14 N N N Y/4 N N N N N Y/2 N N N N N Y/4 
15 N N N N N N N N N N N N N N N N 
16 4600 12000 13000 4400 12300 14000 16000 17200 30000 14000 13000 20400 4600 10400 17000 4400 
17 0.4 0.2 0.26 0.3 0.2 0.2 0.2 0.2 0.2 0.2 0.26 0.3 0.4 0.23 0.3 0.3 
18 60000 2.6 1.5L 87000 1.2L 2.0L 1.2L 1.6L 1.4L 1.6L 1.5L 1.2L 60000 1.4L 1.6L 87000 
19 + + + + + - + - - - - - + + - + 
20 Y N Y Y Y N N N N N N N Y Y N Y 
21 B B B B B B B CSF CSF B B B B B U B 
22 NG NG NG NG NG NG NG NG NG NG NG NG NG NG NG G 
 192  
 
1 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 
2 2582 2583 2613 2635 2637 2640 2644 2666 2689 2690 2692 2693 2694 2719 2721 2752 
3 S NI NI S NI NI S NI NI NI S S NI S NI NI 
4 O I I O I I O I I I O O I O I I 
5 5 8 6 20 7 5 10 7 7 5 6 8 5 5 8 8 
6 M F M M M M F M F M F M M M F M 
7 P T P P P P T P P P P T T T P P 
8 L L L V V L L L V L L N L L L V 
9 N N N N N N N N N Y N N Y Y N Y 
10 Y N N N Y N Y N N N N N N N N N 
11 Y/5 Y/3 Y/6 Y/8 Y/7 Y/5 Y/5 Y/7 Y/7 Y/5 Y/3 Y/3 Y/5 Y/5 Y/3 Y/8 
12 Y N N N Y Y Y N Y N N N Y N N Y 
13 5 8 6 8 7 5 5 7 7 5 3 3 5 5 8 8 
14 N N Y/2 N N N N N N N Y/3 N N Y/2 N N 
15 N N N N N N N N N N N N N N N N 
16 8100 13000 12000 17000 5500 8100 10400 17000 7200 16000 5900 9000 8100 14000 13000 15300 
17 0.2 0.26 0.22 0.3 0.4 0.2 0.23 0.3 0.32 O.22 0.2 0.34 0.2 0.2 0.26 0.34 
18 1.1L 1.5L 2.2L 1.6L 80000 1.1L 1.4L 1.6L 1.0L 1.2L 78000 1.2L 1.1L 1.6L 1.5L 1.3L 
19 + - - + + - + - + + + + + - - - 
20 Y N N Y Y N Y Y Y N Y Y Y N N N 
21 B B B B B B B U B B B B B B B U 
22 NG NG NG NG G NG NG NG G NG NG G NG NG NG NG 
 193  
 
1 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 
2 2753 2756 2767 2768 2770 2795 2797 2798 2820 2839 2867 2873 2943 2956 2966 2988 
3 NI NI PS S NI S NI S S S NI PS S NI S PS 
4 I I O O I O O O O O I O O I O I 
5 35 5 16 5 8 16 5 10 20 8 16 35 15 22 15 10 
6 M M F F M F M M M M M M M M M M 
7 P P T P T T P P T T T T P T P T 
8 V L L V L NW L L NW NW NW L V L L L 
9 N N N Y N L N N Y N N N N N N N 
10 N N N N N Y N N N N N N N N N N 
11 Y/10 Y/5 Y/7 Y/5 Y/7 Y/9 Y/5 Y/7 Y/5 Y/5 Y/7 Y/8 Y/3 Y/8 Y/3 Y/9 
12 N N N Y N Y N N Y N N N N N N Y 
13 10 5 10 5 8 9 5 7 5 5 16 8 3 22 3 10 
14 N N N N Y/3 Y/3 Y/3 N N N N N N N N Y/3 
15 N N Y N N Y/4 N N N N N N N N N Y 
16 20400 8100 17000 8100 13000 4400 12300 16000 8100 10400 17000 12000 13000 12000 13000 4400 
17 0.3 0.2 0.2 0.2 0.26 0.3 0.2 0.3 0.2 0.23 0.3 0.27 0.26 0.27 0.26 0.3 
18 1.2L 1.1L 1.6L 1.1L 1.5L 87000 1.2L 98000 1.1L 1.4L 1.6L 2.6 1.5L 2.6 1.5L 87000 
19 - + - + - + - + + + + + + + + + 
20 N Y N Y N Y N Y Y Y Y N Y N Y Y 
21 U B B B B B B B B B U B B B B B 
22 NG NG NG NG NG NG NG G NG NG NG NG NG NG NG NG 
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 197   
 198  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
